8-K · 2026-11-16
Relmada Therapeutics appoints Jørn Skibsted Jakobsen as Chief Development Officer, enhancing leadership in the pharmaceutical sector.
| Name | RELMADA THERAPEUTICS, INC. |
|---|---|
| CIK | 0001553643 |
| Tickers | RLMD |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 455401931 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | NV NV |
| Phone | 646 876 3459 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Relmada Therapeutics appoints Jørn Skibsted Jakobsen as Chief Development Officer, enhancing leadership in the pharmaceutical sector.
610 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002050709-26-000032 | 005-88207 | 261558231 | 34 | 80859 | |||
| 2026-11-16 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-26-120144 | 001-39082 | 261555532 | 34 | 245168 | 1 | 1 |
| 2026-11-12 | 8-K | CURRENT REPORT | 2.02,7.01,9.01 | 0001213900-26-118933 | 001-39082 | 261547024 | 34 | 12647057 | 1 | 1 |
| 2026-11-12 | 10-Q | QUARTERLY REPORT | 0001213900-26-118916 | 001-39082 | 261546877 | 34 | 4737300 | 1 | 1 | |
| 2026-09-11 | 4 | OWNERSHIP DOCUMENT | 0001213900-26-098970 | 6966 | ||||||
| 2026-09-11 | 4 | xslF345X06/ownership.xml | 0001213900-26-098969 | 7112 | ||||||
| 2026-09-08 | 8-K | CURRENT REPORT | 8.01 | 0001213900-26-097851 | 001-39082 | 261363437 | 34 | 187941 | 1 | 1 |
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002050709-26-000025 | 005-88207 | 261279212 | 34 | 81089 | |||
| 2026-08-06 | 8-K | CURRENT REPORT | 2.02,7.01,9.01 | 0001213900-26-086190 | 001-39082 | 261249915 | 34 | 12625118 | 1 | 1 |
| 2026-08-06 | 10-Q | QUARTERLY REPORT | 0001213900-26-086151 | 001-39082 | 261249254 | 34 | 4832299 | 1 | 1 | |
| 2026-07-29 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-002872 | 005-88207 | 261216935 | 34 | 10901 | |||
| 2026-07-28 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-26-082007 | 001-39082 | 261207629 | 34 | 237185 | 1 | 1 |
| 2026-06-22 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-076490 | 005-88207 | 261108199 | 34 | 16183 | |||
| 2026-06-18 | S-8 | REGISTRATION STATEMENT | 0001213900-26-070097 | 333-296895 | 261102522 | 33 | 534036 | 1 | 1 | |
| 2026-06-09 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001738048-26-000066 | 005-88207 | 261077656 | 34 | 35012 | |||
| 2026-05-28 | 8-K | CURRENT REPORT | 5.03,5.07,9.01 | 0001213900-26-062184 | 001-39082 | 261037581 | 34 | 2474221 | 1 | 1 |
| 2026-05-13 | S-3ASR | REGISTRATION STATEMENT | 0001213900-26-055901 | 333-295855 | 26974276 | 33 | 558975 | 1 | 1 | |
| 2026-05-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-002929 | 005-88207 | 26971248 | 34 | 12645 | |||
| 2026-05-12 | 8-K | CURRENT REPORT | 2.02,7.01,9.01 | 0001213900-26-055164 | 001-39082 | 26969629 | 34 | 16264770 | 1 | 1 |
| 2026-05-12 | 10-Q | QUARTERLY REPORT | 0001213900-26-055059 | 001-39082 | 26968450 | 34 | 4137539 | 1 | 1 | |
| 2026-05-04 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001831942-26-000017 | 005-88207 | 26938066 | 34 | 15340 | |||
| 2026-04-17 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-26-045194 | 001-39082 | 26872026 | 34 | 4096120 | |||
| 2026-04-17 | DEF 14A | PROXY STATEMENT | 0001213900-26-045192 | 001-39082 | 26872006 | 34 | 7420859 | 1 | 1 | |
| 2026-04-09 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001136 | 333-294885 | 26853029 | 33 | 1843 | ||
| 2026-04-09 | 424B3 | PROSPECTUS | 0001213900-26-042007 | 333-294885 | 26851867 | 33 | 200706 | |||
| 2026-04-07 | CORRESP | filename1.htm | 0001213900-26-040821 | 6463 | ||||||
| 2026-04-07 | UPLOAD | filename1.pdf | 0000000000-26-003470 | 333-294885 | 40198 | |||||
| 2026-04-06 | PRE 14A | PROXY STATEMENT | 0001213900-26-040498 | 001-39082 | 26841715 | 34 | 7309871 | 1 | 1 | |
| 2026-04-03 | S-3 | REGISTRATION STATEMENT | 0001213900-26-039967 | 333-294885 | 26838531 | 33 | 4127098 | 1 | 1 | |
| 2026-03-20 | 8-K | CURRENT REPORT | 2.02,7.01,9.01 | 0001213900-26-032403 | 001-39082 | 26778890 | 34 | 12155119 | 1 | 1 |
| 2026-03-19 | 10-K | ANNUAL REPORT | 0001213900-26-031862 | 001-39082 | 26774581 | 34 | 5418627 | 1 | 1 | |
| 2026-03-09 | 8-K | CURRENT REPORT | 1.01,3.02,7.01,8.01,9.01 | 0001213900-26-024918 | 001-39082 | 26733168 | 34 | 9057252 | 1 | 1 |
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002050709-26-000007 | 005-88207 | 26638712 | 34 | 81438 | |||
| 2026-02-17 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-26-001027 | 005-88207 | 26637036 | 34 | 15690 | |||
| 2026-02-12 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-26-000914 | 005-88207 | 26623716 | 34 | 15966 | |||
| 2026-02-06 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001274173-26-000046 | 005-88207 | 26608172 | 34 | 12350 | |||
| 2026-01-30 | 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-26-010313 | 333-281877 | 26584528 | 33 | 27407 | |||
| 2025-12-16 | 4 | xslF345X05/ownership.xml | 0001213900-25-121974 | 7662 | ||||||
| 2025-12-16 | 4 | xslF345X05/ownership.xml | 0001213900-25-121973 | 7008 | ||||||
| 2025-12-16 | 4 | xslF345X05/ownership.xml | 0001213900-25-121972 | 5444 | ||||||
| 2025-12-16 | 4 | xslF345X05/ownership.xml | 0001213900-25-121971 | 5507 | ||||||
| 2025-12-16 | 4 | xslF345X05/ownership.xml | 0001213900-25-121969 | 5485 | ||||||
| 2025-12-16 | 4 | xslF345X05/ownership.xml | 0001213900-25-121968 | 5460 | ||||||
| 2025-12-16 | 4 | xslF345X05/ownership.xml | 0001213900-25-121967 | 5456 | ||||||
| 2025-12-15 | 8-K | CURRENT REPORT | 5.02,9.01 | 0001213900-25-121461 | 001-39082 | 251570054 | 34 | 617368 | 1 | 1 |
| 2025-11-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001193125-25-283441 | 005-88207 | 251488675 | 34 | 155318 | |||
| 2025-11-13 | 8-K | CURRENT REPORT | 2.02,7.01,9.01 | 0001213900-25-110088 | 001-39082 | 251479492 | 34 | 6750423 | 1 | 1 |
| 2025-11-13 | 10-Q | QUARTERLY REPORT | 0001213900-25-109983 | 001-39082 | 251478444 | 34 | 4117170 | 1 | 1 | |
| 2025-11-06 | 4 | xslF345X05/ownership.xml | 0001213900-25-106836 | 4625 | ||||||
| 2025-11-06 | 4 | xslF345X05/ownership.xml | 0001213900-25-106838 | 4596 | ||||||
| 2025-11-06 | 4 | xslF345X05/ownership.xml | 0001213900-25-106837 | 4619 | ||||||
| 2025-11-06 | 4 | xslF345X05/ownership.xml | 0001213900-25-106835 | 4629 | ||||||
| 2025-11-05 | 8-K | CURRENT REPORT | 1.01,7.01,9.01 | 0001213900-25-106398 | 001-39082 | 251451503 | 34 | 675523 | 1 | 1 |
| 2025-11-05 | 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-25-106396 | 333-281877 | 251451501 | 33 | 462385 | |||
| 2025-11-04 | FWP | FREE WRITING PROSPECTUS | 0001213900-25-105641 | 333-281877 | 251446578 | 34 | 81751 | |||
| 2025-11-04 | 8-K | CURRENT REPORT | 7.01,8.01,9.01 | 0001213900-25-105593 | 001-39082 | 251446377 | 34 | 27366074 | 1 | 1 |
| 2025-09-17 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-25-088360 | 001-39082 | 251318789 | 34 | 21827287 | 1 | 1 |
| 2025-09-16 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-25-087926 | 001-39082 | 251315863 | 34 | 210111 | 1 | 1 |
| 2025-09-10 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-25-086389 | 001-39082 | 251304750 | 34 | 8799405 | 1 | 1 |
| 2025-09-02 | 8-K | CURRENT REPORT | 7.01 | 0001213900-25-082910 | 001-39082 | 251282944 | 34 | 190150 | 1 | 1 |
| 2025-08-28 | 4 | xslF345X05/ownership.xml | 0001213900-25-081837 | 8640 | ||||||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002050709-25-000005 | 005-88207 | 251221123 | 34 | 78391 | |||
| 2025-08-07 | 8-K | CURRENT REPORT | 2.02,7.01,9.01 | 0001213900-25-073130 | 001-39082 | 251195163 | 34 | 22048136 | 1 | 1 |
| 2025-08-07 | 10-Q | QUARTERLY REPORT | 0001213900-25-073073 | 001-39082 | 251193915 | 34 | 3881080 | 1 | 1 | |
| 2025-07-23 | 8-K | CURRENT REPORT | 3.01 | 0001213900-25-066995 | 001-39082 | 251143437 | 34 | 196962 | 1 | 1 |
| 2025-07-10 | 8-K | CURRENT REPORT | 1.02 | 0001213900-25-062803 | 001-39082 | 251116613 | 34 | 190727 | 1 | 1 |
| 2025-06-30 | 4 | xslF345X05/ownership.xml | 0001213900-25-059870 | 5433 | ||||||
| 2025-06-30 | 4 | xslF345X05/ownership.xml | 0001213900-25-059869 | 5465 | ||||||
| 2025-06-30 | 4 | xslF345X05/ownership.xml | 0001213900-25-059868 | 5458 | ||||||
| 2025-06-30 | 4 | xslF345X05/ownership.xml | 0001213900-25-059867 | 5442 | ||||||
| 2025-06-30 | 4 | xslF345X05/ownership.xml | 0001213900-25-059866 | 5474 | ||||||
| 2025-06-30 | 4 | xslF345X05/ownership.xml | 0001213900-25-059865 | 5496 | ||||||
| 2025-06-30 | 4 | xslF345X05/ownership.xml | 0001213900-25-059864 | 5469 | ||||||
| 2025-06-18 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-25-055334 | 001-39082 | 251054721 | 34 | 220416 | 1 | 1 |
| 2025-06-13 | S-8 | REGISTRATION STATEMENT | 0001213900-25-053957 | 333-287991 | 251044297 | 33 | 390645 | |||
| 2025-05-27 | 8-K | CURRENT REPORT | 5.07,9.01 | 0001213900-25-047805 | 001-39082 | 25988566 | 34 | 200415 | 1 | 1 |
| 2025-05-20 | 4 | xslF345X05/ownership.xml | 0001213900-25-046088 | 5326 | ||||||
| 2025-05-20 | 4 | xslF345X05/ownership.xml | 0001213900-25-046087 | 8662 | ||||||
| 2025-05-20 | 4 | xslF345X05/ownership.xml | 0001213900-25-046086 | 5289 | ||||||
| 2025-05-20 | 4 | xslF345X05/ownership.xml | 0001213900-25-046085 | 8651 | ||||||
| 2025-05-12 | 10-Q | QUARTERLY REPORT | 0001213900-25-042025 | 001-39082 | 25934760 | 34 | 4126950 | 1 | 1 | |
| 2025-05-12 | 8-K | CURRENT REPORT | 4.01,9.01 | 0001213900-25-042024 | 001-39082 | 25934752 | 34 | 222414 | 1 | 1 |
| 2025-05-01 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0002050709-25-000003 | 005-88207 | 25903468 | 34 | 78103 | |||
| 2025-04-28 | 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-25-035961 | 333-281877 | 25878954 | 33 | 30855 | |||
| 2025-04-28 | 8-K | CURRENT REPORT | 7.01,8.01,9.01 | 0001213900-25-035941 | 001-39082 | 25878721 | 34 | 254670 | 1 | 1 |
| 2025-04-11 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-25-031095 | 001-39082 | 25832297 | 34 | 3905848 | |||
| 2025-04-11 | DEF 14A | PROXY STATEMENT | 0001213900-25-031088 | 001-39082 | 25832273 | 34 | 7864026 | 1 | 1 | |
| 2025-03-27 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001013762-25-003432 | 001-39082 | 25780078 | 34 | 307127 | 1 | 1 |
| 2025-03-27 | 10-K | ANNUAL REPORT | 0001013762-25-003426 | 001-39082 | 25780048 | 34 | 5293118 | 1 | 1 | |
| 2025-03-26 | 8-K | CURRENT REPORT | 1.01,3.02,7.01,9.01 | 0001013762-25-002786 | 001-39082 | 25774126 | 34 | 247482 | 1 | 1 |
| 2025-02-06 | 8-K | CURRENT REPORT | 1.01,7.01,8.01,9.01 | 0001213900-25-010711 | 001-39082 | 25595366 | 34 | 378029 | 1 | 1 |
| 2025-01-27 | 8-K | CURRENT REPORT | 3.01 | 0001213900-25-006727 | 001-39082 | 25555779 | 34 | 204822 | 1 | 1 |
| 2025-01-06 | 8-K | CURRENT REPORT | 5.02,9.01 | 0001213900-25-001249 | 001-39082 | 25512486 | 34 | 781828 | 1 | 1 |
| 2024-12-09 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-24-106646 | 001-39082 | 241533873 | 34 | 240706 | 1 | 1 |
| 2024-12-04 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-24-105245 | 001-39082 | 241524806 | 34 | 223563 | 1 | 1 |
| 2024-11-14 | SC 13G/A | deeptrack-rlmd093024a3.htm | 0001172661-24-004766 | 005-88207 | 241457872 | 34 | 103509 | |||
| 2024-11-07 | 10-Q | QUARTERLY REPORT | 0001213900-24-095398 | 001-39082 | 241435546 | 34 | 3482889 | 1 | 1 | |
| 2024-10-23 | 4 | xslF345X05/ownership.xml | 0001213900-24-089971 | 4603 | ||||||
| 2024-09-12 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-09-12 16:30:00 | 9999999995-24-002821 | 333-281877 | 241296358 | 33 | 1851 | ||
| 2024-09-11 | 4 | OWNERSHIP DOCUMENT | 0001213900-24-077795 | 8677 | ||||||
| 2024-09-11 | 4 | xslF345X05/ownership.xml | 0001213900-24-077794 | 4610 | ||||||
| 2024-09-11 | 4 | xslF345X05/ownership.xml | 0001213900-24-077792 | 8648 | ||||||
| 2024-09-11 | 4 | xslF345X05/ownership.xml | 0001213900-24-077791 | 5304 | ||||||
| 2024-09-11 | CORRESP | filename1.htm | 0001213900-24-077748 | 6282 | ||||||
| 2024-09-06 | UPLOAD | filename1.pdf | 0000000000-24-010111 | 333-281877 | 40188 | |||||
| 2024-08-30 | S-3 | REGISTRATION STATEMENT | 0001213900-24-074553 | 333-281877 | 241270416 | 33 | 650560 | |||
| 2024-08-07 | 10-Q | QUARTERLY REPORT | 0001213900-24-066111 | 001-39082 | 241183587 | 34 | 3168963 | 1 | 1 | |
| 2024-05-30 | 8-K | CURRENT REPORT | 5.07,9.01 | 0001213900-24-047968 | 001-39082 | 241005189 | 34 | 215179 | 1 | 1 |
| 2024-05-29 | 4 | xslF345X05/ownership.xml | 0001213900-24-047639 | 8515 | ||||||
| 2024-05-29 | 4 | xslF345X05/ownership.xml | 0001213900-24-047638 | 8516 | ||||||
| 2024-05-29 | 4 | xslF345X05/ownership.xml | 0001213900-24-047637 | 8497 | ||||||
| 2024-05-29 | 4 | xslF345X05/ownership.xml | 0001213900-24-047636 | 8524 | ||||||
| 2024-05-29 | 4 | xslF345X05/ownership.xml | 0001213900-24-047635 | 8546 | ||||||
| 2024-05-29 | 4 | xslF345X05/ownership.xml | 0001213900-24-047633 | 8484 | ||||||
| 2024-05-29 | 4 | xslF345X05/ownership.xml | 0001213900-24-047632 | 8495 | ||||||
| 2024-05-08 | 10-Q | QUARTERLY REPORT | 0001213900-24-040856 | 001-39082 | 24925877 | 34 | 3062454 | 1 | 1 | |
| 2024-04-09 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-24-031609 | 001-39082 | 24832889 | 34 | 3976310 | |||
| 2024-04-09 | DEF 14A | PROXY STATEMENT | 0001213900-24-031600 | 001-39082 | 24832826 | 34 | 4847937 | |||
| 2024-03-19 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001213900-24-024022 | 001-39082 | 24763286 | 34 | 340159 | 1 | 1 |
| 2024-03-19 | 10-K | ANNUAL REPORT | 0001213900-24-024013 | 001-39082 | 24763060 | 34 | 4604930 | 1 | 1 | |
| 2024-03-06 | SC 13G/A | SC 13G/A | 0001193125-24-060735 | 005-88207 | 24726072 | 34 | 65439 | |||
| 2024-02-20 | 144 | xsl144X01/primary_doc.xml | 0001972362-24-000160 | 001-39082 | 24655353 | 33 | 4355 | |||
| 2024-02-14 | SC 13G/A | deeptrack-rlmd123123a2.htm | 0001172661-24-000937 | 005-88207 | 24632710 | 34 | 103424 | |||
| 2024-02-14 | SC 13G/A | RELMADA THERAPEUTICS, INC. | 0000902664-24-001574 | 005-88207 | 24632386 | 34 | 61791 | |||
| 2024-02-13 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-021823 | 005-88207 | 24629459 | 34 | 13158 | |||
| 2024-01-31 | 4 | xslF345X05/ownership.xml | 0001213900-24-008560 | 8651 | ||||||
| 2024-01-31 | 4 | xslF345X05/ownership.xml | 0001213900-24-008559 | 8655 | ||||||
| 2024-01-31 | 4 | xslF345X05/ownership.xml | 0001213900-24-008557 | 8625 | ||||||
| 2024-01-11 | 8-K | CURRENT REPORT | 5.02 | 0001213900-24-003000 | 001-39082 | 24529571 | 34 | 200390 | 1 | 1 |
| 2024-01-04 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-24-000999 | 001-39082 | 24509812 | 34 | 231014 | 1 | 1 |
| 2024-01-03 | 8-K | CURRENT REPORT | 5.02 | 0001213900-24-000858 | 001-39082 | 24507852 | 34 | 195901 | 1 | 1 |
| 2023-12-19 | 4 | xslF345X05/ownership.xml | 0001213900-23-097032 | 5460 | ||||||
| 2023-12-19 | 4 | xslF345X05/ownership.xml | 0001213900-23-097031 | 5464 | ||||||
| 2023-12-19 | 4 | xslF345X05/ownership.xml | 0001213900-23-097029 | 5446 | ||||||
| 2023-12-19 | 4 | xslF345X05/ownership.xml | 0001213900-23-097028 | 5474 | ||||||
| 2023-12-19 | 4 | xslF345X05/ownership.xml | 0001213900-23-097027 | 5496 | ||||||
| 2023-12-19 | 4 | xslF345X05/ownership.xml | 0001213900-23-097026 | 5447 | ||||||
| 2023-12-19 | 4 | xslF345X05/ownership.xml | 0001213900-23-097024 | 5444 | ||||||
| 2023-11-08 | 10-Q | QUARTERLY REPORT | 0001213900-23-084737 | 001-39082 | 231387758 | 34 | 2906445 | 1 | 1 | |
| 2023-11-08 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001213900-23-084735 | 001-39082 | 231387678 | 34 | 349761 | 1 | 1 |
| 2023-10-11 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001013762-23-002985 | 001-39082 | 231319498 | 34 | 240735 | 1 | 1 |
| 2023-10-10 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001013762-23-002900 | 001-39082 | 231318778 | 34 | 8165201 | 1 | 1 |
| 2023-10-04 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001013762-23-001391 | 001-39082 | 231306660 | 34 | 13869780 | 1 | 1 |
| 2023-09-20 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-23-078049 | 001-39082 | 231266970 | 34 | 301851 | 1 | 1 |
| 2023-09-06 | 8-K | CURRENT REPORT | 5.02,9.01 | 0001213900-23-074165 | 001-39082 | 231238003 | 34 | 200097 | 1 | 1 |
| 2023-08-10 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-23-065674 | 001-39082 | 231160415 | 34 | 7254694 | 1 | 1 |
| 2023-08-08 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001213900-23-064577 | 001-39082 | 231151852 | 34 | 358836 | 1 | 1 |
| 2023-08-08 | 10-Q | QUARTERLY REPORT | 0001213900-23-064519 | 001-39082 | 231151066 | 34 | 2906304 | 1 | 1 | |
| 2023-07-07 | SC 13G/A | us75955j4022_070723.txt | 0001306550-23-009606 | 005-88207 | 231077301 | 34 | 12410 | |||
| 2023-06-21 | S-8 | REGISTRATION STATEMENT | 0001213900-23-050588 | 333-272811 | 231030639 | 33 | 209656 | |||
| 2023-05-30 | 4 | xslF345X04/ownership.xml | 0001213900-23-044093 | 6038 | ||||||
| 2023-05-30 | 4 | xslF345X04/ownership.xml | 0001213900-23-044089 | 6045 | ||||||
| 2023-05-30 | 4 | xslF345X04/ownership.xml | 0001213900-23-044088 | 5984 | ||||||
| 2023-05-30 | 4 | xslF345X04/ownership.xml | 0001213900-23-044087 | 5937 | ||||||
| 2023-05-30 | 4 | xslF345X04/ownership.xml | 0001213900-23-044084 | 5965 | ||||||
| 2023-05-30 | 4 | xslF345X04/ownership.xml | 0001213900-23-044083 | 6123 | ||||||
| 2023-05-30 | 4 | xslF345X04/ownership.xml | 0001213900-23-044081 | 6014 | ||||||
| 2023-05-30 | 4 | xslF345X04/ownership.xml | 0001213900-23-044079 | 5935 | ||||||
| 2023-05-25 | 8-K | CURRENT REPORT | 5.02,5.07,9.01 | 0001213900-23-043101 | 001-39082 | 23961125 | 34 | 423834 | 1 | 1 |
| 2023-05-24 | 4 | OWNERSHIP DOCUMENT | 0001213900-23-042554 | 5328 | ||||||
| 2023-05-15 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-23-040004 | 001-39082 | 23924581 | 34 | 4603086 | 1 | 1 |
| 2023-05-11 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001213900-23-038577 | 001-39082 | 23911834 | 34 | 342857 | 1 | 1 |
| 2023-05-11 | 10-Q | QUARTERLY REPORT | 0001213900-23-038533 | 001-39082 | 23910995 | 34 | 2812232 | 1 | 1 | |
| 2023-04-19 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-23-030851 | 001-39082 | 23828618 | 34 | 10972687 | 1 | 1 |
| 2023-03-31 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-23-025008 | 001-39082 | 23783558 | 34 | 474245 | |||
| 2023-03-31 | DEF 14A | PROXY STATEMENT | 0001213900-23-025007 | 001-39082 | 23783536 | 34 | 4801836 | |||
| 2023-03-23 | 10-K | ANNUAL REPORT | 0001213900-23-022463 | 001-39082 | 23756841 | 34 | 4642960 | 1 | 1 | |
| 2023-03-23 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001213900-23-022428 | 001-39082 | 23756208 | 34 | 346980 | 1 | 1 |
| 2023-03-13 | 8-K | CURRENT REPORT | 7.01 | 0001213900-23-019392 | 001-39082 | 23725820 | 34 | 197579 | 1 | 1 |
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001104659-23-021799 | 005-88207 | 23630744 | 34 | 75035 | |||
| 2023-02-14 | SC 13G/A | SCHEDULE 13G/A, AMENDMENT #1 | 0000899140-23-000385 | 005-88207 | 23629420 | 34 | 63482 | |||
| 2023-02-14 | SC 13G/A | AMENDMENT NO. 1 TO THE SCHEDULE 13G | 0000921895-23-000532 | 005-88207 | 23625112 | 34 | 266128 | |||
| 2023-02-14 | SC 13G/A | RELMADA THERAPEUTICS, INC. | 0000902664-23-001728 | 005-88207 | 23623873 | 34 | 62574 | |||
| 2023-02-14 | SC 13G/A | deeptrack-rlmd123122a1.htm | 0001172661-23-000852 | 005-88207 | 23623092 | 34 | 103341 | |||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001104659-23-020772 | 005-88207 | 23622720 | 34 | 137787 | |||
| 2023-02-09 | SC 13G | SCHEDULE 13G | 0001104659-23-016835 | 005-88207 | 23604104 | 34 | 13053 | |||
| 2023-02-06 | 5/A | OWNERSHIP DOCUMENT | 0001213900-23-008514 | 20013 | ||||||
| 2023-02-02 | 5 | OWNERSHIP DOCUMENT | 0001213900-23-007440 | 17827 | ||||||
| 2023-02-02 | 5 | OWNERSHIP DOCUMENT | 0001213900-23-007438 | 12919 | ||||||
| 2023-02-02 | 5 | OWNERSHIP DOCUMENT | 0001213900-23-007436 | 7086 | ||||||
| 2023-02-01 | SC 13G/A | us75955j4022_020123.txt | 0001306550-23-006526 | 005-88207 | 23577590 | 34 | 13221 | |||
| 2023-01-17 | 8-K | CURRENT REPORT | 1.01,5.02,9.01 | 0001213900-23-002865 | 001-39082 | 23529759 | 34 | 304615 | 1 | 1 |
| 2023-01-13 | 3 | OWNERSHIP DOCUMENT | 0001213900-23-002892 | 3039 | ||||||
| 2023-01-13 | 4 | OWNERSHIP DOCUMENT | 0001213900-23-002871 | 5395 | ||||||
| 2023-01-13 | 3 | OWNERSHIP DOCUMENT | 0001213900-23-002870 | 3681 | ||||||
| 2023-01-09 | 8-K | CURRENT REPORT | 7.01,8.01,9.01 | 0001213900-23-001518 | 001-39082 | 23516769 | 34 | 4504554 | 1 | 1 |
| 2023-01-05 | 8-K | CURRENT REPORT | 1.01,8.01,9.01 | 0001213900-23-001162 | 001-39082 | 23512551 | 34 | 262558 | 1 | 1 |
| 2022-12-28 | 8-K | CURRENT REPORT | 1.01,9.01 | 0001213900-22-083290 | 001-39082 | 221495598 | 34 | 222032 | 1 | 1 |
| 2022-12-20 | 4 | xslF345X03/ownership.xml | 0001213900-22-081520 | 5951 | ||||||
| 2022-12-20 | 4 | xslF345X03/ownership.xml | 0001213900-22-081519 | 5938 | ||||||
| 2022-12-20 | 4 | xslF345X03/ownership.xml | 0001213900-22-081518 | 5942 | ||||||
| 2022-12-20 | 4 | OWNERSHIP DOCUMENT | 0001213900-22-081481 | 5426 | ||||||
| 2022-12-20 | 4 | OWNERSHIP DOCUMENT | 0001213900-22-081479 | 5433 | ||||||
| 2022-12-20 | 4 | OWNERSHIP DOCUMENT | 0001213900-22-081478 | 5411 | ||||||
| 2022-12-20 | 4 | OWNERSHIP DOCUMENT | 0001213900-22-081477 | 5364 | ||||||
| 2022-12-20 | 4 | OWNERSHIP DOCUMENT | 0001213900-22-081475 | 5392 | ||||||
| 2022-12-20 | 4 | OWNERSHIP DOCUMENT | 0001213900-22-081474 | 5402 | ||||||
| 2022-12-20 | 4 | OWNERSHIP DOCUMENT | 0001213900-22-081473 | 5362 | ||||||
| 2022-12-20 | SC 13G | d9893441_13-g.htm | 0000919574-22-007127 | 005-88207 | 221474583 | 34 | 70028 | |||
| 2022-12-12 | 4 | xslF345X03/ownership.xml | 0001213900-22-079244 | 5203 | ||||||
| 2022-12-07 | 8-K | CURRENT REPORT | 7.01,8.01,9.01 | 0001213900-22-078255 | 001-39082 | 221450728 | 34 | 4117847 | 1 | 1 |
| 2022-11-14 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-22-071463 | 001-39082 | 221379646 | 34 | 4356930 | 1 | 1 |
| 2022-11-10 | 8-K | CURRENT REPORT | 2.02,7.01,9.01 | 0001213900-22-071296 | 001-39082 | 221378373 | 34 | 363439 | 1 | 1 |
| 2022-11-10 | 10-Q | QUARTERLY REPORT | 0001213900-22-071154 | 001-39082 | 221377058 | 34 | 3301786 | 1 | 1 | |
| 2022-10-21 | SC 13G | deeptrack-rlmd101322.htm | 0001172661-22-002225 | 005-88207 | 221323813 | 34 | 103305 | |||
| 2022-10-17 | SC 13G | RELMADA THERAPEUTICS, INC. | 0001104659-22-109334 | 005-88207 | 221313845 | 34 | 129315 | |||
| 2022-10-17 | SC 13G | SCHEDULE 13G | 0000899140-22-000751 | 005-88207 | 221312437 | 34 | 59687 | |||
| 2022-10-13 | 8-K | CURRENT REPORT | 7.01,8.01,9.01 | 0001213900-22-063664 | 001-39082 | 221308226 | 34 | 226520 | 1 | 1 |
| 2022-09-23 | SC 13G | SC 13G | 0001193125-22-250190 | 005-88207 | 221262691 | 34 | 66438 | |||
| 2022-09-22 | 8-K | CURRENT REPORT | 1.01,3.02,5.03,9.01 | 0001213900-22-058066 | 001-39082 | 221260078 | 34 | 971189 | 1 | 1 |
| 2022-09-20 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-22-057439 | 001-39082 | 221254075 | 34 | 222813 | 1 | 1 |
| 2022-08-11 | 10-Q | QUARTERLY REPORT | 0001213900-22-046934 | 001-39082 | 221156597 | 34 | 3124011 | 1 | 1 | |
| 2022-07-05 | 4 | xslF345X03/ownership.xml | 0001213900-22-037231 | 19790 | ||||||
| 2022-06-01 | 8-K | CURRENT REPORT | 5.02,5.07,9.01 | 0001213900-22-030586 | 001-39082 | 22986130 | 34 | 418338 | 1 | 1 |
| 2022-05-26 | 4 | xslF345X03/ownership.xml | 0001213900-22-029839 | 8825 | ||||||
| 2022-05-26 | 4 | xslF345X03/ownership.xml | 0001213900-22-029838 | 5918 | ||||||
| 2022-05-26 | 4 | xslF345X03/ownership.xml | 0001213900-22-029837 | 8831 | ||||||
| 2022-05-26 | 4 | xslF345X03/ownership.xml | 0001213900-22-029835 | 5944 | ||||||
| 2022-05-26 | 4 | xslF345X03/ownership.xml | 0001213900-22-029834 | 5969 | ||||||
| 2022-05-26 | 4 | xslF345X03/ownership.xml | 0001213900-22-029833 | 8815 | ||||||
| 2022-05-26 | 4 | xslF345X03/ownership.xml | 0001213900-22-029832 | 5915 | ||||||
| 2022-05-05 | 8-K | CURRENT REPORT | 2.02,8.01,9.01 | 0001213900-22-024268 | 001-39082 | 22897349 | 34 | 5510371 | 1 | 1 |
| 2022-05-05 | 10-Q | 10-Q | 0001213900-22-024229 | 001-39082 | 22896156 | 34 | 2909582 | 1 | 1 | |
| 2022-04-11 | DEF 14A | PROXY STATEMENT | 0001213900-22-019196 | 001-39082 | 22819827 | 34 | 8574360 | |||
| 2022-04-07 | S-3ASR | REGISTRATION STATEMENT | 0001213900-22-018732 | 333-264189 | 22814635 | 33 | 910021 | |||
| 2022-04-05 | 4 | xslF345X03/ownership.xml | 0001213900-22-018223 | 9235 | ||||||
| 2022-04-05 | 4 | xslF345X03/ownership.xml | 0001213900-22-018207 | 16134 | ||||||
| 2022-03-31 | PRE 14A | PROXY STATEMENT | 0001213900-22-016753 | 001-39082 | 22792570 | 34 | 8573734 | |||
| 2022-03-25 | 10-K | ANNUAL REPORT | 0001213900-22-015012 | 001-39082 | 22768256 | 34 | 4581327 | 1 | 1 | |
| 2022-03-23 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001213900-22-014492 | 001-39082 | 22763489 | 34 | 274192 | 1 | 1 |
| 2022-03-07 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-22-010929 | 001-39082 | 22718029 | 34 | 7766301 | 1 | 1 |
| 2022-02-23 | 8-K | CURRENT REPORT | 7.01,8.01,9.01 | 0001213900-22-008783 | 001-39082 | 22660497 | 34 | 6218887 | 1 | 1 |
| 2022-02-14 | SC 13G | SC 13G | 0001104659-22-022875 | 005-88207 | 22632371 | 34 | 229041 | |||
| 2022-02-14 | SC 13G/A | RELMADA THERAPEUTICS, INC. | 0000902664-22-001597 | 005-88207 | 22625712 | 34 | 62549 | |||
| 2022-02-11 | SC 13G/A | RELMADA THERAPEUTICS, INC. | 0000902664-22-001529 | 005-88207 | 22617374 | 34 | 61725 | |||
| 2022-02-03 | SC 13G/A | us75955j4022_020322.txt | 0000834237-22-006299 | 005-88207 | 22589030 | 34 | 13430 | |||
| 2022-01-05 | 4 | xslF345X03/ownership.xml | 0001213900-22-000761 | 6987 | ||||||
| 2021-12-22 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-21-067091 | 001-39082 | 211514099 | 34 | 239003 | 1 | 1 |
| 2021-12-21 | 4 | xslF345X03/ownership.xml | 0001213900-21-066825 | 5348 | ||||||
| 2021-12-21 | 4 | xslF345X03/ownership.xml | 0001213900-21-066824 | 5361 | ||||||
| 2021-12-21 | 4 | xslF345X03/ownership.xml | 0001213900-21-066823 | 5386 | ||||||
| 2021-12-21 | 4 | xslF345X03/ownership.xml | 0001213900-21-066822 | 5355 | ||||||
| 2021-12-21 | 4 | xslF345X03/ownership.xml | 0001213900-21-066821 | 5336 | ||||||
| 2021-12-21 | 4 | xslF345X03/ownership.xml | 0001213900-21-066820 | 5340 | ||||||
| 2021-12-21 | 4 | xslF345X03/ownership.xml | 0001213900-21-066819 | 5332 | ||||||
| 2021-12-20 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-21-066436 | 001-39082 | 211506129 | 34 | 4034337 | 1 | 1 |
| 2021-12-20 | SC 13G | THE SCHEDULE 13G | 0000921895-21-002878 | 005-88207 | 211505850 | 34 | 285895 | |||
| 2021-12-20 | SC 13G | SC 13G | 0001104659-21-151724 | 005-88207 | 211505680 | 34 | 74282 | |||
| 2021-12-13 | 8-K | CURRENT REPORT | 1.01,9.01 | 0001213900-21-065014 | 001-39082 | 211488768 | 34 | 553098 | 1 | 1 |
| 2021-12-10 | 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-21-064733 | 333-245054 | 211485869 | 33 | 612658 | |||
| 2021-12-08 | 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-21-064200 | 333-245054 | 211479109 | 33 | 633105 | |||
| 2021-12-07 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-21-063985 | 001-39082 | 211476803 | 34 | 712488 | 1 | 1 |
| 2021-11-23 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-21-061444 | 001-39082 | 211435552 | 34 | 4038407 | 1 | 1 |
| 2021-11-15 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-21-058993 | 001-39082 | 211406557 | 34 | 4354774 | 1 | 1 |
| 2021-11-12 | 10-Q | QUARTERLY REPORT | 0001213900-21-058454 | 001-39082 | 211400321 | 34 | 3493705 | 1 | 1 | |
| 2021-10-07 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-21-051860 | 001-39082 | 211312943 | 34 | 4742121 | 1 | 1 |
| 2021-09-24 | 4 | xslF345X03/ownership.xml | 0001213900-21-049820 | 11697 | ||||||
| 2021-08-19 | 4 | xslF345X03/ownership.xml | 0001213900-21-043907 | 6950 | ||||||
| 2021-08-10 | 10-Q | QUARTERLY REPORT | 0001213900-21-041369 | 001-39082 | 211159845 | 34 | 3569625 | 1 | 1 | |
| 2021-07-20 | 8-K | CURRENT REPORT | 1.01 | 0001213900-21-037756 | 001-39082 | 211101642 | 34 | 31857 | ||
| 2021-07-16 | 4 | xslF345X03/ownership.xml | 0001213900-21-037273 | 7052 | ||||||
| 2021-07-06 | S-8 | REGISTRATION STATEMENT | 0001213900-21-035802 | 333-257723 | 211075096 | 33 | 279468 | |||
| 2021-06-22 | 4/A | xslF345X03/ownership.xml | 0001213900-21-033647 | 4444 | ||||||
| 2021-06-02 | 4 | xslF345X03/ownership.xml | 0001213900-21-030571 | 7051 | ||||||
| 2021-05-20 | 8-K | CURRENT REPORT | 5.02,5.07,9.01 | 0001213900-21-028217 | 001-39082 | 21945492 | 34 | 188478 | ||
| 2021-05-12 | 10-Q | QUARTERLY REPORT | 0001213900-21-025786 | 001-39082 | 21914988 | 34 | 2512206 | 1 | ||
| 2021-05-05 | 4 | xslF345X03/ownership.xml | 0001213900-21-024716 | 5350 | ||||||
| 2021-04-05 | 4 | xslF345X03/ownership.xml | 0001213900-21-020123 | 7054 | ||||||
| 2021-03-31 | DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-21-019299 | 001-39082 | 21794324 | 34 | 6281416 | |||
| 2021-03-24 | 10-K | ANNUAL REPORT | 0001213900-21-017556 | 001-39082 | 21769312 | 34 | 4864662 | 1 | ||
| 2021-03-23 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001213900-21-017294 | 001-39082 | 21765101 | 34 | 94705 | ||
| 2021-03-15 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-21-015427 | 001-39082 | 21742501 | 34 | 27369 | ||
| 2021-03-15 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-21-015425 | 001-39082 | 21742450 | 34 | 25771 | ||
| 2021-03-11 | 4 | OWNERSHIP DOCUMENT | 0001213900-21-014918 | 12721 | ||||||
| 2021-03-11 | 4 | xslF345X03/ownership.xml | 0001213900-21-014917 | 10997 | ||||||
| 2021-03-10 | 4 | xslF345X03/ownership.xml | 0001213900-21-014656 | 14204 | ||||||
| 2021-03-02 | 4 | xslF345X03/ownership.xml | 0001213900-21-012891 | 5351 | ||||||
| 2021-02-26 | 4 | xslF345X03/ownership.xml | 0001213900-21-012174 | 12689 | ||||||
| 2021-02-26 | 4 | xslF345X03/ownership.xml | 0001213900-21-012171 | 12700 | ||||||
| 2021-02-26 | 4 | xslF345X03/ownership.xml | 0001213900-21-012169 | 10987 | ||||||
| 2021-02-17 | 4 | xslF345X03/ownership.xml | 0001213900-21-010148 | 6974 | ||||||
| 2021-02-16 | 4 | xslF345X03/ownership.xml | 0001213900-21-009699 | 9281 | ||||||
| 2021-02-16 | 4 | xslF345X03/ownership.xml | 0001213900-21-009696 | 9285 | ||||||
| 2021-02-16 | SC 13G/A | SC 13G/A | 0001104659-21-024243 | 005-88207 | 21639693 | 34 | 73427 | |||
| 2021-02-16 | SC 13G/A | AMENDMENT NO. 2 | 0001214659-21-001972 | 005-88207 | 21638639 | 34 | 81687 | |||
| 2021-02-16 | SC 13G/A | SC 13G/A | 0001104659-21-023959 | 005-88207 | 21638363 | 34 | 149677 | |||
| 2021-02-12 | SC 13G/A | form-sc13ga.htm | 0001493152-21-003511 | 005-88207 | 21623436 | 34 | 193327 | |||
| 2021-02-12 | SC 13G | RELMADA THERAPEUTICS, INC. | 0000902664-21-001234 | 005-88207 | 21622903 | 34 | 59675 | |||
| 2021-02-10 | 4 | xslF345X03/ownership.xml | 0001213900-21-008204 | 12688 | ||||||
| 2021-02-10 | 4 | xslF345X03/ownership.xml | 0001213900-21-008203 | 10997 | ||||||
| 2021-02-10 | 4 | xslF345X03/ownership.xml | 0001213900-21-008202 | 12691 | ||||||
| 2021-02-04 | 4 | xslF345X03/ownership.xml | 0001213900-21-006837 | 6942 | ||||||
| 2021-02-04 | 4 | xslF345X03/ownership.xml | 0001213900-21-006834 | 10836 | ||||||
| 2021-02-04 | 4 | xslF345X03/ownership.xml | 0001213900-21-006832 | 10839 | ||||||
| 2021-02-03 | 4 | xslF345X03/ownership.xml | 0001213900-21-006570 | 14500 | ||||||
| 2021-02-02 | 4 | xslF345X03/ownership.xml | 0001213900-21-006210 | 7050 | ||||||
| 2021-02-02 | SC 13G | us75955j4022_020221.txt | 0000834237-21-006932 | 005-88207 | 21580677 | 34 | 13402 | |||
| 2021-01-29 | 4 | xslF345X03/ownership.xml | 0001213900-21-005451 | 10983 | ||||||
| 2021-01-29 | 4 | xslF345X03/ownership.xml | 0001213900-21-005448 | 12499 | ||||||
| 2021-01-29 | 4 | xslF345X03/ownership.xml | 0001213900-21-005443 | 12694 | ||||||
| 2021-01-27 | 4/A | OWNERSHIP DOCUMENT | 0001213900-21-004515 | 4822 | ||||||
| 2021-01-27 | 4/A | xslF345X03/ownership.xml | 0001213900-21-004512 | 5694 | ||||||
| 2021-01-26 | 4 | xslF345X03/ownership.xml | 0001213900-21-004482 | 14394 | ||||||
| 2021-01-26 | 4 | xslF345X03/ownership.xml | 0001213900-21-004480 | 14380 | ||||||
| 2021-01-26 | 4 | xslF345X03/ownership.xml | 0001213900-21-004478 | 14381 | ||||||
| 2021-01-11 | 4 | xslF345X03/ownership.xml | 0001213900-21-001432 | 5296 | ||||||
| 2021-01-11 | 4 | xslF345X03/ownership.xml | 0001213900-21-001429 | 5350 | ||||||
| 2021-01-11 | 4 | xslF345X03/ownership.xml | 0001213900-21-001426 | 5325 | ||||||
| 2021-01-11 | 4 | OWNERSHIP DOCUMENT | 0001213900-21-001421 | 5329 | ||||||
| 2021-01-11 | 4 | xslF345X03/ownership.xml | 0001213900-21-001419 | 7828 | ||||||
| 2021-01-11 | 4 | xslF345X03/ownership.xml | 0001213900-21-001416 | 7830 | ||||||
| 2021-01-11 | 4 | xslF345X03/ownership.xml | 0001213900-21-001414 | 7821 | ||||||
| 2021-01-07 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-21-000805 | 001-39082 | 21513032 | 34 | 6397162 | ||
| 2021-01-05 | 8-K | FORM 8-K | 5.02 | 0001213900-21-000428 | 001-39082 | 21505354 | 34 | 17508 | ||
| 2021-01-05 | 4 | xslF345X03/ownership.xml | 0001213900-21-000426 | 5021 | ||||||
| 2020-12-14 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-20-042571 | 001-39082 | 201387045 | 34 | 4557610 | ||
| 2020-12-08 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-20-041596 | 001-39082 | 201375521 | 34 | 104746 | ||
| 2020-12-02 | 4 | xslF345X03/ownership.xml | 0001213900-20-040481 | 6651 | ||||||
| 2020-11-16 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-20-037155 | 001-39082 | 201313944 | 34 | 7763691 | ||
| 2020-11-12 | 10-Q | QUARTERLY REPORT | 0001213900-20-036542 | 001-39082 | 201306845 | 34 | 2624849 | 1 | ||
| 2020-11-03 | 4 | xslF345X03/ownership.xml | 0001213900-20-034800 | 5022 | ||||||
| 2020-10-27 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-20-033559 | 001-39082 | 201264724 | 34 | 36144 | ||
| 2020-10-02 | 4 | xslF345X03/ownership.xml | 0001213900-20-029901 | 5022 | ||||||
| 2020-09-02 | 4 | xslF345X03/ownership.xml | 0001213900-20-025044 | 6176 | ||||||
| 2020-08-21 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2020-08-21 16:00:00 | 9999999995-20-002225 | 333-245054 | 201124499 | 33 | 1778 | ||
| 2020-08-19 | CORRESP | filename1.htm | 0001213900-20-022900 | 11304 | ||||||
| 2020-08-19 | 4 | OWNERSHIP DOCUMENT | 0001213900-20-022888 | 8664 | ||||||
| 2020-08-19 | 4 | OWNERSHIP DOCUMENT | 0001213900-20-022883 | 8655 | ||||||
| 2020-08-19 | 4 | xslF345X03/ownership.xml | 0001213900-20-022881 | 9784 | ||||||
| 2020-08-18 | UPLOAD | filename1.pdf | 0000000000-20-007613 | 40316 | ||||||
| 2020-08-12 | S-3 | REGISTRATION STATEMENT | 0001213900-20-021662 | 333-245054 | 201096282 | 33 | 514075 | |||
| 2020-08-12 | 10-Q | QUARTERLY REPORT | 0001213900-20-021649 | 001-39082 | 201096083 | 34 | 2621151 | 1 | ||
| 2020-08-04 | 4 | xslF345X03/ownership.xml | 0001213900-20-020143 | 6180 | ||||||
| 2020-07-02 | 4 | xslF345X03/ownership.xml | 0001213900-20-016524 | 6180 | ||||||
| 2020-06-11 | SC 13G | 13G | 0001493215-20-000002 | 005-88207 | 20956267 | 34 | 13644 | |||
| 2020-06-03 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-20-013981 | 001-39082 | 20939079 | 34 | 17082334 | ||
| 2020-05-15 | 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-20-012700 | 333-234262 | 20886987 | 33 | 468415 | |||
| 2020-05-15 | 10-Q | QUARTERLY REPORT | 0001213900-20-012693 | 001-39082 | 20886927 | 34 | 2859502 | 1 | ||
| 2020-04-09 | 4 | xslF345X03/ownership.xml | 0001213900-20-008907 | 10301 | ||||||
| 2020-04-06 | 8-K/A | AMENDMENT TO FILED CURRENT REPORT | 5.02 | 0001213900-20-008650 | 001-39082 | 20777303 | 34 | 20725 | ||
| 2020-03-26 | 10-KT | TRANSITION REPORT | 0001213900-20-007501 | 001-39082 | 20746246 | 34 | 5100378 | 1 | ||
| 2020-03-18 | 4 | OWNERSHIP DOCUMENT | 0001213900-20-006781 | 6700 | ||||||
| 2020-03-16 | 3 | xslF345X02/ownership.xml | 0001213900-20-006563 | 4385 | ||||||
| 2020-03-12 | 8-K | CURRENT REPORT | 1.01,5.02,9.01 | 0001213900-20-006126 | 001-39082 | 20709162 | 34 | 79066 | ||
| 2020-03-09 | 8-K | CURRENT REPORT | 1.01,5.07,9.01 | 0001213900-20-005746 | 001-39082 | 20698176 | 34 | 34111 | ||
| 2020-02-28 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-20-005062 | 001-39082 | 20672341 | 34 | 30084 | |||
| 2020-02-14 | SC 13G | SC 13G | 0001104659-20-021898 | 005-88207 | 20620910 | 34 | 65574 | |||
| 2020-02-14 | SC 13G/A | AMENDMENT NO. 1 - RLMD | 0001214659-20-001483 | 005-88207 | 20619119 | 34 | 82822 | |||
| 2020-01-31 | DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-20-002274 | 001-39082 | 20565426 | 34 | 2581521 | |||
| 2020-01-10 | 8-K | CURRENT REPORT | 1.01,5.02,9.01 | 0001213900-20-000758 | 001-39082 | 20521228 | 34 | 302447 | ||
| 2020-01-07 | 3/A | xslF345X02/ownership.xml | 0001213900-20-000389 | 4628 | ||||||
| 2020-01-06 | 3 | xslF345X02/ownership.xml | 0001213900-20-000271 | 5041 | ||||||
| 2019-12-27 | 4 | xslF345X03/ownership.xml | 0001213900-19-027115 | 14617 | ||||||
| 2019-12-26 | 8-K | CURRENT REPORT | 5.02,5.03,8.01,9.01 | 0001213900-19-026923 | 001-39082 | 191308367 | 34 | 205506 | ||
| 2019-12-23 | 3 | xslF345X02/ownership.xml | 0001213900-19-026866 | 7077 | ||||||
| 2019-12-23 | 4 | xslF345X03/ownership.xml | 0001213900-19-026862 | 5319 | ||||||
| 2019-12-23 | 4 | xslF345X03/ownership.xml | 0001213900-19-026859 | 5331 | ||||||
| 2019-12-23 | 4 | xslF345X03/ownership.xml | 0001213900-19-026855 | 5343 | ||||||
| 2019-12-23 | 4 | xslF345X03/ownership.xml | 0001213900-19-026852 | 5335 | ||||||
| 2019-12-23 | 4 | xslF345X03/ownership.xml | 0001213900-19-026850 | 5332 | ||||||
| 2019-12-23 | 4 | xslF345X03/ownership.xml | 0001213900-19-026848 | 5336 | ||||||
| 2019-12-16 | SC 13G | SC 13G | 0001104659-19-073088 | 005-88207 | 191288010 | 34 | 366250 | |||
| 2019-12-06 | 8-K | CURRENT REPORT | 1.01,9.01 | 0001213900-19-025518 | 001-39082 | 191273163 | 34 | 282048 | ||
| 2019-12-05 | 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-19-025441 | 333-234262 | 191271227 | 33 | 662339 | |||
| 2019-12-03 | 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-19-025209 | 333-234262 | 191266009 | 33 | 661463 | |||
| 2019-12-03 | 8-K | CURRENT REPORT | 1.01,8.01,9.01 | 0001213900-19-025202 | 001-39082 | 191265844 | 34 | 7924546 | ||
| 2019-11-13 | 10-Q | QUARTERLY REPORT | 0001213900-19-023219 | 001-39082 | 191214760 | 34 | 2897633 | 1 | ||
| 2019-11-01 | 424B3 | PROSPECTUS | 0001213900-19-021807 | 333-229258 | 191186963 | 33 | 605381 | |||
| 2019-10-31 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2019-10-31 16:00:00 | 9999999995-19-002448 | 333-234262 | 191185068 | 33 | 1778 | ||
| 2019-10-31 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001213900-19-021146,2019-10-31 | 9999999995-19-002434 | 333-229258 | 191185057 | 33 | 1791 | ||
| 2019-10-31 | SC 13G | p1030190sc13g.htm | 0001214659-19-006748 | 005-88207 | 191184180 | 34 | 90652 | |||
| 2019-10-30 | CORRESP | filename1.htm | 0001213900-19-021477 | 19000 | ||||||
| 2019-10-28 | CORRESP | filename1.htm | 0001213900-19-021295 | 11100 | ||||||
| 2019-10-28 | S-3/A | AMENDMENT NO. 1 TO FORM S-3 | 0001213900-19-021291 | 333-234262 | 191173859 | 33 | 331191 | |||
| 2019-10-25 | POS AM | REGISTRATION STATEMENT | 0001213900-19-021146 | 333-229258 | 191169930 | 33 | 679015 | |||
| 2019-10-25 | UPLOAD | filename1.pdf | 0000000000-19-014861 | 50964 | ||||||
| 2019-10-24 | 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-19-021040 | 333-233228 | 191166837 | 33 | 1287358 | |||
| 2019-10-23 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2019-10-23 16:00:00 | 9999999995-19-002370 | 333-233228 | 191164694 | 33 | 1778 | ||
| 2019-10-21 | CORRESP | filename1.htm | 0001213900-19-020749 | 8832 | ||||||
| 2019-10-21 | 4 | xslF345X03/ownership.xml | 0001213900-19-020722 | 4457 | ||||||
| 2019-10-21 | 8-K | CURRENT REPORT | 7.01,8.01,9.01 | 0001213900-19-020718 | 001-39082 | 191159764 | 34 | 3036265 | ||
| 2019-10-21 | 4 | xslF345X03/ownership.xml | 0001213900-19-020706 | 13343 | ||||||
| 2019-10-18 | S-3 | REGISTRATION STATEMENT | 0001213900-19-020629 | 333-234262 | 191158372 | 33 | 433111 | |||
| 2019-10-18 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-19-020604 | 001-39082 | 191157848 | 34 | 3703142 | 1 | |
| 2019-10-17 | CORRESP | filename1.htm | 0001213900-19-020563 | 9405 | ||||||
| 2019-10-17 | S-1/A | AMENDMENT NO. 2 TO FORM S-1 | 0001213900-19-020561 | 333-233228 | 191155770 | 33 | 4925445 | 1 | ||
| 2019-10-16 | UPLOAD | filename1.pdf | 0000000000-19-014620 | 49440 | ||||||
| 2019-10-11 | CORRESP | filename1.htm | 0001213900-19-020213 | 12222 | ||||||
| 2019-10-11 | S-1/A | AMENDMENT NO. 1 TO FORM S-1 | 0001213900-19-020211 | 333-233228 | 191148354 | 33 | 4947476 | 1 | ||
| 2019-10-08 | D | xslFormDX01/primary_doc.xml | 06b | 0001213900-19-019994 | 021-350641 | 191143133 | 33 | 11156 | ||
| 2019-10-08 | CERT | 8A_Cert_RLMD.pdf | 0001354457-19-000504 | 001-39082 | 191142202 | 34 | 86718 | |||
| 2019-10-08 | 8-A12B | FORM 8-A12B | 0001213900-19-019910 | 001-39082 | 191141561 | 34 | 16037 | |||
| 2019-10-01 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-19-019395 | 000-55347 | 191129343 | 34 | 34039 | ||
| 2019-09-27 | 8-K | FORM 8-K | 3.03,5.03,9.01 | 0001213900-19-019122 | 000-55347 | 191120725 | 34 | 259919 | ||
| 2019-09-24 | 10-K | ANNUAL REPORT | 0001213900-19-018787 | 000-55347 | 191110777 | 34 | 4250289 | 1 | ||
| 2019-09-23 | SEC STAFF ACTION | filename1.pdf | 9999999997-19-007069 | 121164 | ||||||
| 2019-08-20 | UPLOAD | filename1.pdf | 0000000000-19-012673 | 45138 | ||||||
| 2019-08-12 | S-1 | REGISTRATION STATEMENT | 0001213900-19-015376 | 333-233228 | 191017568 | 33 | 6017603 | 1 | ||
| 2019-07-30 | 3 | xslF345X02/ownership.xml | 0001213900-19-014047 | 4381 | ||||||
| 2019-07-30 | 4 | xslF345X03/ownership.xml | 0001213900-19-014045 | 5350 |
One latest value per concept from companyfacts (482 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 106.69M | 2026-11-10 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 18.89M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 12.04M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-17 | 0001213900-26-045192 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 5.63M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-17 | 0001213900-26-045192 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 19.46M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-17 | 0001213900-26-045192 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 8.89M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-17 | 0001213900-26-045192 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 15.06 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-17 | 0001213900-26-045192 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 0 | 2026-05-12 | S-3ASR | 2026-05-13 | 0001213900-26-055901 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 0 | 2026-05-12 | S-3ASR | 2026-05-13 | 0001213900-26-055901 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 50.00M | 2026-05-12 | S-3ASR | 2026-05-13 | 0001213900-26-055901 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-05-12 | S-3ASR | 2026-05-13 | 0001213900-26-055901 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-05-12 | S-3ASR | 2026-05-13 | 0001213900-26-055901 | |||
| invest | InvestmentWarrantsExercisePrice | Investment Warrants, Exercise Price | USD | 1.5 | 2014-07-01 | 2014-12-31 | 2015 | Q2 | 10-Q | 2015-02-13 | 0001213900-15-001037 |
| us-gaap | AccountsAndOtherReceivablesNetCurrent | Accounts and Other Receivables, Net, Current | USD | 10,912 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrent | Accounts Payable and Accrued Liabilities, Current | USD | 5.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent | Accounts Payable and Accrued Liabilities | USD | 5.57M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0001213900-23-084737 | |
| us-gaap | AccountsPayableAndAccruedLiabilitiesNoncurrent | Accounts Payable and Accrued Liabilities, Noncurrent | USD | 100,000 | 2015-03-31 | 2015 | Q3 | 10-Q | 2015-05-15 | 0001213900-15-003882 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 2.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | AccountsPayableInterestBearingInterestRate | Accounts Payable, Interest-bearing, Interest Rate | pure | 0.07 | 2018-06-30 | 2019 | FY | 10-KT | 2020-03-26 | 0001213900-20-007501 | |
| us-gaap | AccruedBonusesCurrent | Accrued Bonuses, Current | USD | 1.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | AccruedBonusesCurrentAndNoncurrent | Accrued Bonuses | USD | 621,600 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-07 | 0001213900-24-066111 | |
| us-gaap | AccruedLiabilitiesAndOtherLiabilities | Accrued Liabilities and Other Liabilities | USD | 8.69M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 5.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | AccruedLiabilitiesCurrentAndNoncurrent | Accrued Liabilities | USD | 5.36M | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-07 | 0001213900-24-066111 | |
| us-gaap | AccruedLiabilitiesFairValueDisclosure | Accrued Liabilities, Fair Value Disclosure | USD | 0 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001213900-22-024229 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 311,100 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | AccruedProfessionalFeesCurrentAndNoncurrent | Accrued Professional Fees | USD | 240,300 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-07 | 0001213900-24-066111 | |
| us-gaap | AccruedVacationCurrent | Accrued Vacation, Current | USD | 588,500 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | AccruedVacationCurrentAndNoncurrent | Accrued Vacation | USD | 395,000 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-07 | 0001213900-24-066111 | |
| us-gaap | AccumulatedAmortizationDeferredFinanceCosts | Accumulated Amortization, Debt Issuance Costs | USD | 0 | 2014-06-30 | 2014 | FY | 10-KT | 2014-09-09 | 0001213900-14-006474 | |
| us-gaap | AccumulatedCapitalizedInterestCosts | Accumulated Capitalized Interest Costs | USD | 522,869 | 2018-10-31 | 2019 | FY | 10-KT | 2020-03-26 | 0001213900-20-007501 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 16,700 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-25 | 0001213900-22-015012 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease | Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment, Period Increase (Decrease) | USD | 550 | 2011-05-23 | 2014-02-28 | 2014 | Q2 | 10-Q | 2014-04-15 | 0001255294-14-000328 |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 937.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | AdjustmentOfWarrantsGrantedForServices | Adjustment of Warrants Granted for Services | USD | -59,397 | 2018-07-01 | 2019-06-30 | 2020 | FY | 10-K | 2021-03-24 | 0001213900-21-017556 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions | APIC, Share-based Payment Arrangement, Recognition and Exercise | USD | 11.17M | 2023-04-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0001213900-23-064519 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition | USD | 1.02M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 199,879 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 1.26M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0001213900-23-022463 |
| us-gaap | AdvertisingExpense | Advertising Expense | USD | 5,759 | 2011-05-23 | 2014-02-28 | 2014 | Q2 | 10-Q | 2014-04-15 | 0001255294-14-000328 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 2.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | AllocatedShareBasedCompensationExpenseNetOfTax | Share-based Payment Arrangement, Expense, after Tax | USD | 3.20M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 |
| us-gaap | AmortizationOfDebtDiscountPremium | Amortization of Debt Discount (Premium) | USD | 661,168 | 2018-07-01 | 2019-06-30 | 2020 | FY | 10-K | 2021-03-24 | 0001213900-21-017556 |
| us-gaap | AmortizationOfFinancingCosts | Amortization of Debt Issuance Costs | USD | 6.53M | 2017-07-01 | 2018-06-30 | 2019 | FY | 10-KT | 2020-03-26 | 0001213900-20-007501 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 16.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | Assets | Assets | USD | 205.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 205.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued | Business Acquisition, Equity Interest Issued or Issuable, Number of Shares | shares | 5.66M | 2014-05-15 | 2014-05-20 | 2015 | FY | 10-K | 2015-09-11 | 0001213900-15-006928 |
| us-gaap | BusinessCombinationConsiderationTransferred1 | Business Combination, Consideration Transferred | USD | 100,000 | 2013-01-01 | 2013-12-31 | 2014 | Q3 | 8-K | 2014-05-27 | 0001213900-14-003773 |
| us-gaap | BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage | Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage | pure | 0.809 | 2014-05-20 | 2015 | FY | 10-K | 2015-09-11 | 0001213900-15-006928 | |
| us-gaap | BusinessDevelopment | Business Development | USD | 200.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | Cash | Cash | USD | 42.52M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071154 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 5.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | -24.05M | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-15 | 0001213900-20-012693 |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 202.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 5.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 14.47M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0001213900-23-064519 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | 2.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 9.07M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0001213900-23-064519 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 2.09M | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-07 | 0001213900-24-066111 | |
| us-gaap | CashFDICInsuredAmount | Cash, FDIC Insured Amount | USD | 2.50M | 2020-12-31 | 2020 | FY | 10-K | 2021-03-24 | 0001213900-21-017556 | |
| us-gaap | CashPeriodIncreaseDecrease | Cash, Period Increase (Decrease) | USD | -11.12M | 2015-07-01 | 2016-03-31 | 2016 | Q3 | 10-Q | 2016-05-09 | 0001213900-16-013088 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights | Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) | USD/Warrant | 0.01 | 2013-12-31 | 2014 | Q3 | 8-K | 2014-05-27 | 0001213900-14-003773 | |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 0.001 | 2025-11-05 | 2025 | Q3 | 10-Q | 2025-11-13 | 0001213900-25-109983 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 1.26M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0001213900-23-022463 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 5,417 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071154 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 597,374 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0001213900-23-084737 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 200.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 106.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 106.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | CommonStockSharesSubscribedButUnissued | Common Stock, Shares Subscribed but Unissued | shares | 2.13M | 2013-05-31 | 2013 | Q3 | 10-Q | 2013-07-12 | 0001255294-13-000523 | |
| us-gaap | CommonStockSharesSubscriptions | Common Stock, Value, Subscriptions | USD | 8,500 | 2013-05-31 | 2013 | Q3 | 10-Q | 2013-07-12 | 0001255294-13-000523 | |
| us-gaap | CommonStocksIncludingAdditionalPaidInCapital | Common Stocks, Including Additional Paid in Capital | USD | 1.01M | 2012-04-30 | 2014 | FY | 10-KT | 2014-09-09 | 0001213900-14-006474 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 106,695 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | ContractualObligation | Contractual Obligation | USD | 33,000 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0001213900-21-058454 | |
| us-gaap | ContractualObligationDueAfterFifthYear | Contractual Obligation, to be Paid, after Year Five | USD | 94,385 | 2016-09-30 | 2017 | Q1 | 10-Q | 2016-11-10 | 0001213900-16-018211 | |
| us-gaap | ContractualObligationDueInNextTwelveMonths | Contractual Obligation, to be Paid, Year One | USD | 90,348 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-25 | 0001213900-22-015012 | |
| us-gaap | ContractualObligationDueInSecondYear | Contractual Obligation, to be Paid, Year Two | USD | 2.73M | 2018-09-30 | 2019 | Q1 | 10-Q | 2018-11-13 | 0001213900-18-015476 | |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 246,747 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0001013762-25-003426 |
| us-gaap | ConversionOfStockSharesIssued1 | Conversion of Stock, Shares Issued | shares | 2.68M | 2018-10-03 | 2018-10-18 | 2020 | FY | 10-K | 2021-03-24 | 0001213900-21-017556 |
| us-gaap | ConvertibleDebtFairValueDisclosures | Convertible Debt, Fair Value Disclosures | USD | 958,861 | 2012-12-31 | 2014 | FY | 10-KT | 2014-09-09 | 0001213900-14-006474 | |
| us-gaap | ConvertibleNotesPayable | Convertible Notes Payable | USD | 7.21M | 2018-06-30 | 2019 | FY | 10-KT | 2020-03-26 | 0001213900-20-007501 | |
| us-gaap | ConvertibleNotesPayableCurrent | Convertible Notes Payable, Current | USD | 148,321 | 2014-09-30 | 2015 | Q1 | 10-Q | 2014-11-07 | 0001213900-14-007845 | |
| us-gaap | CostOfGoodsAndServicesSold | Cost of Goods and Services Sold | USD | 12,206 | 2011-05-23 | 2014-02-28 | 2014 | Q2 | 10-Q | 2014-04-15 | 0001255294-14-000328 |
| us-gaap | CumulativeEarningsDeficit | Cumulative Earnings (Deficit) | USD | 424.17M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071154 | |
| us-gaap | CurrentFederalStateAndLocalTaxExpenseBenefit | Current Federal, State and Local, Tax Expense (Benefit) | USD | 88.61M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 |
| us-gaap | DebtConversionConvertedInstrumentAmount1 | Debt Conversion, Converted Instrument, Amount | USD | 11.80M | 2018-10-02 | 2018-10-31 | 2019 | FY | 10-KT | 2020-03-26 | 0001213900-20-007501 |
| us-gaap | DebtConversionConvertedInstrumentSharesIssued1 | Debt Conversion, Converted Instrument, Shares Issued | shares | 2.68M | 2018-10-02 | 2018-10-31 | 2019 | FY | 10-KT | 2020-03-26 | 0001213900-20-007501 |
| us-gaap | DebtInstrumentConvertibleBeneficialConversionFeature | Debt Instrument, Convertible, Beneficial Conversion Feature | USD | 186,727 | 2014-01-01 | 2014-06-30 | 2015 | FY | 10-K | 2015-09-11 | 0001213900-15-006928 |
| us-gaap | DebtInstrumentConvertibleConversionPrice1 | Debt Instrument, Convertible, Conversion Price | USD/shares | 0.75 | 2018-06-30 | 2018 | FY | 10-K | 2018-09-28 | 0001213900-18-013238 | |
| us-gaap | DebtInstrumentDecreaseForgiveness | Debt Instrument, Decrease, Forgiveness | USD | 353,246 | 2012-01-01 | 2012-12-31 | 2014 | FY | 10-KT | 2014-09-09 | 0001213900-14-006474 |
| us-gaap | DebtInstrumentInterestRateDuringPeriod | Debt Instrument, Interest Rate During Period | pure | 0.07 | 2018-10-03 | 2018-10-18 | 2020 | FY | 10-K | 2021-03-24 | 0001213900-21-017556 |
| us-gaap | DebtInstrumentInterestRateEffectivePercentage | Debt Instrument, Interest Rate, Effective Percentage | pure | 0.03 | 2015-03-31 | 2015 | Q3 | 10-Q | 2015-05-15 | 0001213900-15-003882 | |
| us-gaap | DebtInstrumentInterestRateStatedPercentage | Debt Instrument, Interest Rate, Stated Percentage | pure | 0.031 | 2019-06-30 | 2020 | FY | 10-K | 2021-03-24 | 0001213900-21-017556 | |
| us-gaap | DebtInstrumentUnamortizedDiscount | Debt Instrument, Unamortized Discount | USD | 3.89M | 2018-10-18 | 2019 | FY | 10-KT | 2020-03-26 | 0001213900-20-007501 | |
| us-gaap | DebtInstrumentUnamortizedDiscountNoncurrent | Debt Instrument, Unamortized Discount, Noncurrent | USD | 0 | 2019-12-31 | 2019 | FY | 10-KT | 2020-03-26 | 0001213900-20-007501 | |
| us-gaap | DeferredFinanceCostsCurrentNet | Debt Issuance Costs, Current, Net | USD | 78,724 | 2013-12-31 | 2014 | FY | 10-KT | 2014-09-09 | 0001213900-14-006474 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 42.73M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0001213900-23-022463 | |
| us-gaap | DeferredRentCreditNoncurrent | Deferred Rent Credit, Noncurrent | USD | 0 | 2017-06-30 | 2017 | FY | 10-K | 2017-09-28 | 0001213900-17-010097 | |
| us-gaap | DeferredTaxAssetsCapitalLossCarryforwards | Deferred Tax Assets, Capital Loss Carryforwards | USD | 49.58M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 3.54M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 122.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 4.76M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 6.20M | 2017-12-22 | 8-K | 2019-10-18 | 0001213900-19-020604 | |||
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsDomestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | USD | 127.04M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0001013762-25-003426 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsForeign | Deferred Tax Assets, Operating Loss Carryforwards, Foreign | USD | 51.75M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | USD | 2.72M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 11,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 3.95M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0001013762-25-003426 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits | USD | 191,000 | 2017-06-30 | 2018 | FY | 10-K | 2018-09-28 | 0001213900-18-013238 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseOther | Deferred Tax Assets, Tax Deferred Expense, Other | USD | 7.76M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0001013762-25-003426 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | USD | 1.61M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 | |
| us-gaap | DeferredTaxAssetsUnrealizedLossesOnTradingSecurities | Deferred Tax Assets, Unrealized Losses on Trading Securities | USD | 7.76M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 122.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 | |
| us-gaap | DeferredTaxAssetsValuationAllowanceCurrent | Deferred Tax Assets, Valuation Allowance, Current | USD | -3.95M | 2018-06-30 | 2018 | FY | 10-K | 2018-09-28 | 0001213900-18-013238 | |
| us-gaap | DeferredTaxExpenseFromStockOptionsExercised | Deferred Tax Expense from Stock Options Exercised | USD | 703,720 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0001213900-23-022463 |
| us-gaap | DefinedBenefitPlanContributionsByEmployer | Defined Benefit Plan, Plan Assets, Contributions by Employer | USD | 118,800 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0001213900-23-084737 |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 156,700 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercentOfMatch | Defined Contribution Plan, Employer Matching Contribution, Percent of Match | pure | 0.5 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent | pure | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | Deposits | Deposits | USD | 36.28M | 2019-12-31 | 2019 | FY | 10-KT | 2020-03-26 | 0001213900-20-007501 | |
| us-gaap | Depreciation | Depreciation | USD | 1,258 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0001213900-23-022463 |
| us-gaap | DepreciationExpenseOnReclassifiedAssets | Depreciation Expense on Reclassified Assets | USD | 1,258 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-25 | 0001213900-22-015012 |
| us-gaap | DerivativeGainLossOnDerivativeNet | Derivative, Gain (Loss) on Derivative, Net | USD | -54,634 | 2018-07-01 | 2019-06-30 | 2020 | FY | 10-K | 2021-03-24 | 0001213900-21-017556 |
| us-gaap | DerivativeLiabilities | Derivative Liability | USD | 4.19M | 2018-06-30 | 2020 | FY | 10-K | 2021-03-24 | 0001213900-21-017556 | |
| us-gaap | DerivativeLiabilitiesCurrent | Derivative Liability, Current | USD | 4.19M | 2018-06-30 | 2019 | FY | 10-KT | 2020-03-26 | 0001213900-20-007501 | |
| us-gaap | DevelopmentInProcess | Development in Process | USD | 200.00M | 2025-03-25 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | USD | 85.16M | 2014-09-30 | 2015 | Q1 | 10-Q | 2014-11-07 | 0001213900-14-007845 | |
| us-gaap | DirectOperatingCosts | Direct Operating Costs | USD | 19.43M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001213900-22-024229 |
| us-gaap | DirectTaxesAndLicensesCosts | Cost, Direct Tax and License | USD | 7,529 | 2017-06-01 | 2017-06-08 | 2023 | Q2 | 10-Q | 2023-08-08 | 0001213900-23-064519 |
| us-gaap | DividendsShareBasedCompensation | Dividend, Share-based Payment Arrangement | USD | 1.31M | 2012-04-01 | 2012-04-30 | 2014 | FY | 10-KT | 2014-09-09 | 0001213900-14-006474 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.44 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -7.16 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-25 | 0001213900-22-015012 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.44 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.102 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | -0.026 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent | pure | 0.022 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0001013762-25-003426 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.02 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0.052 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent | pure | -0.008 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount | USD | 8.87M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | -0.155 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | 0.014 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 |
| us-gaap | EmployeeBenefitsAndShareBasedCompensation | Employee Benefits and Share-based Compensation | USD | 12,562 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001213900-24-095398 |
| us-gaap | EmployeeBenefitsAndShareBasedCompensationNoncash | Employee Benefit and Share-based Payment Arrangement, Noncash | USD | 12,562 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001213900-24-095398 |
| us-gaap | EmployeeRelatedLiabilitiesCurrentAndNoncurrent | Employee-related Liabilities | USD | 117,000 | 2015-09-30 | 2016 | Q1 | 10-Q | 2015-11-06 | 0001213900-15-008265 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 8.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions | Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount | USD | 900,000 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001213900-24-095398 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 7.49M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 | |
| us-gaap | EmployeeStockOwnershipPlanESOPCompensationExpense | Employee Stock Ownership Plan (ESOP), Compensation Expense | USD | 101,100 | 2021-01-01 | 2021-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071154 |
| us-gaap | EntertainmentLicenseAgreementForProgramMaterialCapitalizedCost | Entertainment, License Agreement for Program Material, Capitalized Cost | USD | 12.70M | 2021-07-16 | 2024 | FY | 10-K | 2025-03-27 | 0001013762-25-003426 | |
| us-gaap | EquityMethodInvestmentOwnershipPercentage | Equity Method Investment, Ownership Percentage | pure | 0.946 | 2014-05-20 | 2015 | FY | 10-K | 2015-09-11 | 0001213900-15-006928 | |
| us-gaap | ExcessStockSharesAuthorized | Excess Stock, Shares Authorized | shares | 13,000 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-12 | 0001213900-21-025786 | |
| us-gaap | ExcessStockSharesIssued | Excess Stock, Shares Issued | shares | 8.82M | 2021-12-08 | 2022 | FY | 10-K | 2023-03-23 | 0001213900-23-022463 | |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 1.93M | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-12 | 0001213900-21-025786 |
| us-gaap | FairValueAssumptionsExercisePrice | Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31) | USD | 0.8 | 2013-12-31 | 2014 | FY | 10-KT | 2014-09-09 | 0001213900-14-006474 | |
| us-gaap | FairValueAssumptionsExpectedDividendRate | Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) | pure | 0 | 2017-07-01 | 2018-03-31 | 2018 | Q3 | 10-Q | 2018-05-14 | 0001213900-18-006121 |
| us-gaap | FairValueAssumptionsExpectedVolatilityRate | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) | pure | 0.916 | 2017-07-01 | 2018-03-31 | 2018 | Q3 | 10-Q | 2018-05-14 | 0001213900-18-006121 |
| us-gaap | FairValueAssumptionsRiskFreeInterestRate | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) | pure | 0.022 | 2017-07-01 | 2018-03-31 | 2018 | Q3 | 10-Q | 2018-05-14 | 0001213900-18-006121 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | USD | -46.82M | 2014-09-30 | 2015 | Q1 | 10-Q | 2014-11-07 | 0001213900-14-007845 | |
| us-gaap | FairValueNetAssetLiability | Fair Value, Net Asset (Liability) | USD | 12,562 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001213900-24-095398 | |
| us-gaap | FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations | FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations | USD | 4,425 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 |
| us-gaap | FeesAndCommissions | Fees and Commissions (Deprecated 2018-01-31) | USD | 586,200 | 2014-07-01 | 2014-09-30 | 2015 | Q1 | 10-Q | 2014-11-07 | 0001213900-14-007845 |
| us-gaap | GainLossOnDispositionOfIntangibleAssets | Gain (Loss) on Disposition of Intangible Assets | USD | -96,403 | 2016-07-01 | 2017-06-30 | 2018 | FY | 10-K | 2018-09-28 | 0001213900-18-013238 |
| us-gaap | GainLossOnSaleOfInvestments | Gain (Loss) on Sale of Investments | USD | -66.43M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-10 | 0001213900-21-041369 |
| us-gaap | GainLossOnSaleOfLeasedAssetsNetOperatingLeases | Gain (Loss) on Sale of Leased Assets, Net, Operating Leases | USD | 100,000 | 2017-06-01 | 2017-06-06 | 2018 | FY | 10-K | 2018-09-28 | 0001213900-18-013238 |
| us-gaap | GainLossRelatedToLitigationSettlement | Gain (Loss) Related to Litigation Settlement | USD | 6.35M | 2022-01-01 | 2022-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0001213900-23-084737 |
| us-gaap | GainOnSaleOfInvestments | Gain on Sale of Investments | USD | 611,382 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0001213900-23-022463 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | 6.35M | 2022-01-01 | 2022-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0001213900-23-064519 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 21.87M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | GeneralPartnersOfferingCosts | General Partners' Offering Costs | USD | 161.23M | 2022-09-30 | 2022 | FY | 10-K | 2023-03-23 | 0001213900-23-022463 | |
| us-gaap | GrantsReceivableCurrent | Grants Receivable, Current | USD | 3.61M | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001213900-22-024229 | |
| us-gaap | GrossProfit | Gross Profit | USD | 3,396 | 2011-05-23 | 2014-02-28 | 2014 | Q2 | 10-Q | 2014-04-15 | 0001255294-14-000328 |
| us-gaap | IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | -125.75M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-25 | 0001213900-22-015012 |
| us-gaap | IncomeLossFromEquityMethodInvestments | Income (Loss) from Equity Method Investments | USD | -666,708 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0001213900-23-064519 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 1.35M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-07 | 0001213900-25-073073 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 5.83M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -12.05M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 461,515 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 1.15M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | -3.46M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 812,027 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 969,641 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 512,432 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0001213900-23-022463 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 375,533 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | IncreaseDecreaseInAccruedTaxesPayable | Increase (Decrease) in Accrued Taxes Payable | USD | 275 | 2011-05-23 | 2013-05-31 | 2013 | Q3 | 10-Q | 2013-07-12 | 0001255294-13-000523 |
| us-gaap | IncreaseDecreaseInDeferredCompensation | Increase (Decrease) in Deferred Compensation | USD | 3,038 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-12 | 0001213900-25-042025 |
| us-gaap | IncreaseDecreaseInDeferredLiabilities | Increase (Decrease) in Deferred Liabilities | USD | -3,836 | 2016-07-01 | 2016-12-31 | 2018 | Q2 | 10-Q | 2018-02-12 | 0001213900-18-001597 |
| us-gaap | IncreaseDecreaseInDerivativeLiabilities | Increase (Decrease) in Derivative Liabilities | USD | 54,634 | 2018-07-01 | 2019-06-30 | 2020 | FY | 10-K | 2021-03-24 | 0001213900-21-017556 |
| us-gaap | IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption | Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option | USD | -26.11M | 2014-07-01 | 2014-09-30 | 2015 | Q1 | 10-Q | 2014-11-07 | 0001213900-14-007845 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | -6,124 | 2011-05-23 | 2014-02-28 | 2014 | Q2 | 10-Q | 2014-04-15 | 0001255294-14-000328 |
| us-gaap | IncreaseDecreaseInLeasingReceivables | Increase (Decrease) in Leasing Receivables | USD | -86,377 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 |
| us-gaap | IncreaseDecreaseInOtherCurrentAssets | Increase (Decrease) in Other Current Assets | USD | 256,192 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-11 | 0001213900-22-046934 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentLiabilities | Increase (Decrease) in Other Noncurrent Liabilities | USD | -1,493 | 2016-07-01 | 2017-03-31 | 2018 | Q3 | 10-Q | 2018-05-14 | 0001213900-18-006121 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | 6,092 | 2019-01-01 | 2019-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001213900-20-036542 |
| us-gaap | IncreaseDecreaseInOtherReceivables | Increase (Decrease) in Other Receivables | USD | 10,912 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001213900-26-086151 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 2.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense | USD | 402,430 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001213900-26-055059 |
| us-gaap | IncreaseDecreaseInPrepaidExpensesOther | Increase (Decrease) in Prepaid Expenses, Other | USD | -637,035 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-07 | 0001213900-24-066111 |
| us-gaap | IncreaseDecreaseInReceivables | Increase (Decrease) in Receivables | USD | -512,432 | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-11 | 0001213900-23-038533 |
| us-gaap | InterestAndOtherIncome | Interest and Other Income | USD | 1.29M | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-11 | 0001213900-23-038533 |
| us-gaap | InterestExpense | Interest Expense | USD | 2,814 | 2015-07-01 | 2015-12-31 | 2016 | Q2 | 10-Q | 2016-02-05 | 0001213900-16-010641 |
| us-gaap | InterestIncomeExpenseNet | Interest Income (Expense), Net | USD | 5.15M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 |
| us-gaap | InterestIncomeExpenseNonoperatingNet | Interest Income (Expense), Nonoperating, Net | USD | -706,460 | 2017-07-01 | 2018-03-31 | 2018 | Q3 | 10-Q | 2018-05-14 | 0001213900-18-006121 |
| us-gaap | InterestIncomeOther | Interest Income, Other | USD | 2,300 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001213900-22-024229 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 1,969 | 2017-07-01 | 2017-09-30 | 2017 | Q1 | 10-Q | 2017-11-14 | 0001213900-17-012121 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 2,415 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-25 | 0001213900-22-015012 |
| us-gaap | InterestPayableCurrent | Interest Payable, Current | USD | 371,600 | 2018-06-30 | 2019 | FY | 10-KT | 2020-03-26 | 0001213900-20-007501 | |
| us-gaap | InterestReceivable | Interest Receivable | USD | 566,180 | 2012-04-30 | 2014 | FY | 10-KT | 2014-09-09 | 0001213900-14-006474 | |
| us-gaap | InventoryFinishedGoods | Inventory, Finished Goods, Gross | USD | 6,124 | 2014-02-28 | 2014 | Q2 | 10-Q | 2014-04-15 | 0001255294-14-000328 | |
| us-gaap | InventoryWriteDown | Inventory Write-down | USD | 377 | 2011-05-23 | 2014-02-28 | 2014 | Q2 | 10-Q | 2014-04-15 | 0001255294-14-000328 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 5.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | InvestmentIncomeInterestAndDividend | Investment Income, Interest and Dividend | USD | 1.17M | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001213900-20-036542 |
| us-gaap | IssuanceOfStockAndWarrantsForServicesOrClaims | Issuance of Stock and Warrants for Services or Claims | USD | 10.24M | 2021-01-01 | 2021-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071154 |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 15,900 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-12 | 0001213900-21-025786 |
| us-gaap | LeaseCost | Lease, Cost | USD | 6,550 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-25 | 0001213900-22-015012 |
| us-gaap | LeaseIncentiveReceivableCurrent | Lease Incentive Receivable, Current | USD | 81,133 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-12 | 0001213900-21-025786 | |
| us-gaap | LeaseIncentiveReceivableNoncurrent | Lease Incentive Receivable, Noncurrent | USD | 65,454 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-12 | 0001213900-21-025786 | |
| us-gaap | LeaseIncome | Lease Income | USD | 2,500 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071154 |
| us-gaap | LegalFees | Legal Fees | USD | 79,000 | 2018-07-01 | 2019-06-30 | 2019 | FY | 10-KT | 2020-03-26 | 0001213900-20-007501 |
| us-gaap | LesseeOperatingLeaseDiscountRate | Lessee, Operating Lease, Discount Rate | pure | 0.084 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0001213900-23-084737 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 11,000 | 2021-08-01 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 90,348 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-25 | 0001213900-22-015012 | |
| us-gaap | LessorOperatingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount | Lessor, Operating Lease, Assumptions and Judgments, Value of Underlying Asset, Amount | USD | 493,452 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 | |
| us-gaap | LettersOfCreditOutstandingAmount | Letters of Credit Outstanding, Amount | USD | 390,800 | 2016-03-31 | 2016 | Q3 | 10-Q | 2016-05-09 | 0001213900-16-013088 | |
| us-gaap | Liabilities | Liabilities | USD | 11.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 205.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 7.78M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | LicenseAndServicesRevenue | License and Services Revenue (Deprecated 2018-01-31) | USD | 7,529 | 2016-07-01 | 2017-06-30 | 2017 | FY | 10-K | 2017-09-28 | 0001213900-17-010097 |
| us-gaap | LicenseCosts | License Costs (Deprecated 2018-01-31) | USD | 16,620 | 2016-07-01 | 2017-06-30 | 2017 | FY | 10-K | 2017-09-28 | 0001213900-17-010097 |
| us-gaap | LineOfCredit | Long-term Line of Credit | USD | 0 | 2017-06-30 | 2017 | FY | 10-K | 2017-09-28 | 0001213900-17-010097 | |
| us-gaap | LineOfCreditFacilityAmountOutstanding | Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) | USD | 975,000 | 2012-04-30 | 2014 | Q3 | 8-K | 2014-05-27 | 0001213900-14-003773 | |
| us-gaap | LineOfCreditFacilityIncreaseDecreaseForPeriodNet | Line of Credit Facility, Increase (Decrease), Net | USD | 234,400 | 2016-07-01 | 2017-03-31 | 2017 | Q3 | 10-Q | 2017-05-15 | 0001213900-17-005185 |
| us-gaap | LitigationReserveCurrent | Estimated Litigation Liability, Current | USD | 275,000 | 2017-03-31 | 2017 | Q3 | 10-Q | 2017-05-15 | 0001213900-17-005185 | |
| us-gaap | LoansPayableCurrent | Loans Payable, Current | USD | 900,000 | 2013-12-31 | 2014 | FY | 10-KT | 2014-09-09 | 0001213900-14-006474 | |
| us-gaap | LongtermDebtPercentageBearingFixedInterestAmount | Long-term Debt, Percentage Bearing Fixed Interest, Amount | USD | 39,990 | 2013-12-31 | 2014 | Q3 | 8-K | 2014-05-27 | 0001213900-14-003773 | |
| us-gaap | LongTermNotesPayable | Notes Payable, Noncurrent | USD | 2.66M | 2018-06-30 | 2019 | FY | 10-KT | 2020-03-26 | 0001213900-20-007501 | |
| us-gaap | LossOnSaleOfInvestments | Loss on Sale of Investments | USD | 4.22M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0001213900-23-022463 |
| us-gaap | MalpracticeLossContingencyDiscountRate | Malpractice Loss Contingency, Discount Rate | pure | 0.084 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 150.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 3.96M | 2017-07-01 | 2017-09-30 | 2017 | Q1 | 10-Q | 2017-11-14 | 0001213900-17-012121 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -110.69M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -2,591 | 2017-07-01 | 2017-09-30 | 2017 | Q1 | 10-Q | 2017-11-14 | 0001213900-17-012121 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -37.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | -979,048 | 2017-07-01 | 2017-09-30 | 2017 | Q1 | 10-Q | 2017-11-14 | 0001213900-17-012121 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -45.83M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | NetIncomeLossAttributableToNoncontrollingInterest | Net Income (Loss) Attributable to Noncontrolling Interest | USD | -39.75M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001213900-22-024229 |
| us-gaap | NetIncomeLossAttributableToParentDiluted | Net Income (Loss) Attributable to Parent, Diluted | USD | 342,700 | 2015-07-01 | 2016-03-31 | 2017 | Q3 | 10-Q | 2017-05-15 | 0001213900-17-005185 |
| us-gaap | NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1 | New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets (Deprecated 2020-01-31) | USD | 59,397 | 2018-06-30 | 2019 | FY | 10-KT | 2020-03-26 | 0001213900-20-007501 | |
| us-gaap | NoncashOrPartNoncashAcquisitionPayablesAssumed1 | Noncash or Part Noncash Acquisition, Payables Assumed | USD | 90 | 2020-01-01 | 2020-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0001213900-21-058454 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 1.74M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | NotesPayable | Notes Payable | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-24 | 0001213900-21-017556 | |
| us-gaap | NotesPayableCurrent | Notes Payable, Current | USD | 110,247 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-24 | 0001213900-21-017556 | |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segments | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 47.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -47.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 138,600 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | OperatingLeaseLeaseIncome | Operating Lease, Lease Income | USD | 4,900 | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-15 | 0001213900-20-012693 |
| us-gaap | OperatingLeaseLeaseIncomeLeasePayments | Operating Lease, Lease Income, Lease Payments | USD | 397,049 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 2.28M | 2016-06-30 | 2016 | FY | 10-K | 2016-09-09 | 0001213900-16-016664 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 357,400 | 2016-06-30 | 2016 | FY | 10-K | 2016-09-09 | 0001213900-16-016664 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 356,700 | 2016-06-30 | 2016 | FY | 10-K | 2016-09-09 | 0001213900-16-016664 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 346,800 | 2016-06-30 | 2016 | FY | 10-K | 2016-09-09 | 0001213900-16-016664 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 334,600 | 2016-06-30 | 2016 | FY | 10-K | 2016-09-09 | 0001213900-16-016664 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 333,000 | 2016-06-30 | 2016 | FY | 10-K | 2016-09-09 | 0001213900-16-016664 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 551,900 | 2016-06-30 | 2016 | FY | 10-K | 2016-09-09 | 0001213900-16-016664 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsReceivable | Operating Leases, Future Minimum Payments Receivable | USD | 180,696 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-24 | 0001213900-21-017556 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsReceivableCurrent | Operating Leases, Future Minimum Payments Receivable, Current | USD | 90,348 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-24 | 0001213900-21-017556 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsReceivableInFourYears | Operating Leases, Future Minimum Payments Receivable, in Four Years | USD | 45,175 | 2019-06-30 | 8-K | 2019-10-18 | 0001213900-19-020604 | |||
| us-gaap | OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears | Operating Leases, Future Minimum Payments Receivable, in Three Years | USD | 90,348 | 2019-12-31 | 2019 | FY | 10-KT | 2020-03-26 | 0001213900-20-007501 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears | Operating Leases, Future Minimum Payments Receivable, in Two Years | USD | 90,348 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-24 | 0001213900-21-017556 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsReceivableThereafter | Operating Leases, Future Minimum Payments Receivable, Thereafter | USD | 45,174 | 2018-06-30 | 2018 | FY | 10-K | 2018-09-28 | 0001213900-18-013238 | |
| us-gaap | OperatingLeasesRentExpenseSubleaseRentals1 | Operating Leases, Rent Expense, Sublease Rentals | USD | 2,350 | 2016-09-19 | 2016-09-30 | 2018 | FY | 10-K | 2018-09-28 | 0001213900-18-013238 |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 4.76M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 367,800 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | OtherAccruedLiabilitiesCurrentAndNoncurrent | Other Accrued Liabilities | USD | 69,700 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-07 | 0001213900-24-066111 | |
| us-gaap | OtherAssets | Other Assets | USD | 11,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 256,192 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-11 | 0001213900-22-046934 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 247,379 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | OtherCommitment | Other Commitment | USD | 2.80M | 2015-03-31 | 2015 | Q3 | 10-Q | 2015-05-15 | 0001213900-15-003882 | |
| us-gaap | OtherDepreciationAndAmortization | Other Depreciation and Amortization | USD | 1,258 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0001213900-21-058454 |
| us-gaap | OtherEmployeeRelatedLiabilitiesCurrent | Other Employee-related Liabilities, Current | USD | 129,300 | 2015-12-31 | 2016 | Q2 | 10-Q | 2016-02-05 | 0001213900-16-010641 | |
| us-gaap | OtherExtraordinaryGainLoss | Other Extraordinary Gain (Loss) (Deprecated 2019-01-31) | USD | 3.77M | 2018-07-01 | 2018-12-31 | 2019 | Q2 | 10-Q | 2019-02-13 | 0001213900-19-002391 |
| us-gaap | OtherGeneralExpense | Other General Expense | USD | 1,500 | 2014-07-01 | 2014-09-30 | 2015 | Q1 | 10-Q | 2014-11-07 | 0001213900-14-007845 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 140,914 | 2016-06-30 | 2017 | FY | 10-K | 2017-09-28 | 0001213900-17-010097 | |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | 1.80M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-25 | 0001213900-22-015012 |
| us-gaap | OtherNonoperatingIncome | Other Nonoperating Income | USD | 2,350 | 2017-07-01 | 2018-06-30 | 2019 | FY | 10-KT | 2020-03-26 | 0001213900-20-007501 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -623,568 | 2017-07-01 | 2018-03-31 | 2018 | Q3 | 10-Q | 2018-05-14 | 0001213900-18-006121 |
| us-gaap | OtherOperatingActivitiesCashFlowStatement | Other Operating Activities, Cash Flow Statement | USD | 54.21M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0001213900-21-058454 |
| us-gaap | OtherPartnersCapital | Other Partners' Capital | USD | 100.00M | 2022-04-06 | 2023 | Q1 | 10-Q | 2023-05-11 | 0001213900-23-038533 | |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 160,600 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | OtherReceivables | Other Receivables | USD | 177,000 | 2019-06-30 | 2020 | FY | 10-K | 2021-03-24 | 0001213900-21-017556 | |
| us-gaap | OtherReceivablesNetCurrent | Other Receivables, Net, Current | USD | 512,432 | 2022-12-31 | 2023 | Q3 | 10-Q | 2023-11-08 | 0001213900-23-084737 | |
| us-gaap | OtherResearchAndDevelopmentExpense | Other Research and Development Expense | USD | 905,226 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-12 | 0001213900-25-042025 |
| us-gaap | OtherShortTermInvestments | Other Short-term Investments | USD | 92.23M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 | |
| us-gaap | PaymentsForDeposits | Payments for Deposits | USD | 44.44M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-25 | 0001213900-22-015012 |
| us-gaap | PaymentsForFees | Payments for Other Fees | USD | 3.50M | 2025-03-25 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | PaymentsForProceedsFromInvestments | Payments for (Proceeds from) Investments | USD | 447,723 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001213900-22-024229 |
| us-gaap | PaymentsForPurchaseOfInvestmentOperatingActivity | PaymentsForPurchaseOfInvestmentOperatingActivity | USD | 250,000 | 2025-02-05 | 2025 | Q3 | 10-Q | 2025-11-13 | 0001213900-25-109983 | |
| us-gaap | PaymentsForPurchaseOfOtherAssets1 | Payments for Purchase of Other Assets | USD | 2.76M | 2025-02-05 | 2025 | Q3 | 10-Q | 2025-11-13 | 0001213900-25-109983 | |
| us-gaap | PaymentsForRent | Payments for Rent | USD | 4,500 | 2025-01-01 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 9.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | PaymentsOfFinancingCosts | Payments of Financing Costs | USD | 98,463 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 131,924 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 57.15M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0001213900-23-084737 |
| us-gaap | PaymentsToAcquireProductiveAssets | Payments to Acquire Productive Assets | USD | 182.05M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-24 | 0001213900-21-017556 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | -1,800 | 2011-05-23 | 2014-02-28 | 2014 | Q2 | 10-Q | 2014-04-15 | 0001255294-14-000328 |
| us-gaap | PaymentsToAcquireShortTermInvestments | Payments to Acquire Short-term Investments | USD | 199.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | PreferredStockIncludingAdditionalPaidInCapitalNetOfDiscount | Preferred Stock, Including Additional Paid in Capital, Net of Discount | USD | 0 | 2020-07-22 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001213900-20-036542 | |
| us-gaap | PreferredStockLiquidationPreference | Preferred Stock, Liquidation Preference Per Share | USD/shares | 0.8 | 2014-06-30 | 2014 | FY | 10-KT | 2014-09-09 | 0001213900-14-006474 | |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 200.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2014-02-28 | 2014 | Q2 | 10-Q | 2014-04-15 | 0001255294-14-000328 | |
| us-gaap | PrepaidExpenseAndOtherAssets | Prepaid Expense and Other Assets | USD | 2.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 798,094 | 2016-06-30 | 2016 | FY | 10-K | 2016-09-09 | 0001213900-16-016664 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 2.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | PrepaidExpenseCurrentAndNoncurrent | Prepaid Expense | USD | 537,500 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-07 | 0001213900-24-066111 | |
| us-gaap | PrepaidInsurance | Prepaid Insurance | USD | 740,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | PrepaidRent | Prepaid Rent | USD | 9,000 | 2021-08-01 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071154 | |
| us-gaap | PrepaidTaxes | Prepaid Taxes | USD | 6,000 | 2018-12-31 | 2019 | Q2 | 10-Q | 2019-02-13 | 0001213900-19-002391 | |
| us-gaap | ProceedsFromCollectionOfLeaseReceivables | Proceeds from Collection of Lease Receivables | USD | 50,000 | 2015-07-01 | 2016-06-30 | 2016 | FY | 10-K | 2016-09-09 | 0001213900-16-016664 |
| us-gaap | ProceedsFromDebtNetOfIssuanceCosts | Proceeds from Debt, Net of Issuance Costs | USD | 42.73M | 2020-05-01 | 2020-05-15 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071154 |
| us-gaap | ProceedsFromDivestitureOfBusinessesNetOfCashDivested | Proceeds from Divestiture of Businesses, Net of Cash Divested | USD | 246,747 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 |
| us-gaap | ProceedsFromFeesReceived | Proceeds from Fees Received | USD | 7,529 | 2017-06-01 | 2017-06-08 | 2023 | Q3 | 10-Q | 2023-11-08 | 0001213900-23-084737 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 42.73M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0001213900-23-022463 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 160.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan | Proceeds from Issuance of Common Stock, Dividend Reinvestment Plan | USD | 184.64M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-25 | 0001213900-22-015012 |
| us-gaap | ProceedsFromIssuanceOfDebt | Proceeds from Issuance of Debt | USD | 39,990 | 2004-05-25 | 2014-03-31 | 2014 | Q3 | 8-K | 2014-05-27 | 0001213900-14-003773 |
| us-gaap | ProceedsFromIssuanceOfPreferredStockAndPreferenceStock | Proceeds from Issuance of Preferred Stock and Preference Stock | USD | 3.49M | 2013-01-01 | 2013-12-31 | 2014 | FY | 10-KT | 2014-09-09 | 0001213900-14-006474 |
| us-gaap | ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants | Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants | USD | 3.49M | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2015-09-11 | 0001213900-15-006928 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 22.23M | 2014-01-01 | 2014-06-30 | 2015 | FY | 10-K | 2015-09-11 | 0001213900-15-006928 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 1.26M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0001213900-23-022463 |
| us-gaap | ProceedsFromIssuanceOrSaleOfEquity | Proceeds from Issuance or Sale of Equity | USD | 19.79M | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-12 | 0001213900-21-025786 |
| us-gaap | ProceedsFromLicenseFeesReceived | Proceeds from License Fees Received | USD | 7,529 | 2022-12-08 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 | |
| us-gaap | ProceedsFromNotesPayable | Proceeds from Notes Payable | USD | 6.53M | 2017-07-01 | 2018-06-30 | 2019 | FY | 10-KT | 2020-03-26 | 0001213900-20-007501 |
| us-gaap | ProceedsFromRelatedPartyDebt | Proceeds from Related Party Debt | USD | 3.49M | 2004-05-25 | 2014-03-31 | 2014 | Q3 | 8-K | 2014-05-27 | 0001213900-14-003773 |
| us-gaap | ProceedsFromRepaymentsOfNotesPayable | Proceeds from (Repayments of) Notes Payable | USD | -110,247 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001213900-20-036542 |
| us-gaap | ProceedsFromSaleAndCollectionOfLeaseReceivables | Proceeds from Sale and Collection of Lease Receivables | USD | 96,403 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 |
| us-gaap | ProceedsFromSaleAndMaturityOfOtherInvestments | Proceeds from Sale and Maturity of Other Investments | USD | 168.86M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-25 | 0001213900-22-015012 |
| us-gaap | ProceedsFromSaleOfShortTermInvestments | Proceeds from Sale of Short-term Investments | USD | 88.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 119,247 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 42.73M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071154 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 1,683 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | ProfessionalFees | Professional Fees | USD | 25,000 | 2015-05-01 | 2015-05-31 | 2017 | Q3 | 10-Q | 2017-05-15 | 0001213900-17-005185 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -39.75M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001213900-22-024229 |
| us-gaap | ProgramRightsObligationsNoncurrent | Program Rights Obligations, Noncurrent | USD | 3.78M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 16,700 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-25 | 0001213900-22-015012 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 1,258 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-25 | 0001213900-22-015012 | |
| us-gaap | PropertyPlantAndEquipmentOther | Property, Plant and Equipment, Other, Gross | USD | 1,300 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-25 | 0001213900-22-015012 | |
| us-gaap | RealizedInvestmentGainsLosses | Realized Investment Gains (Losses) | USD | -482,284 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | ReceivablesNetCurrent | Receivables, Net, Current | USD | 512,432 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 | |
| us-gaap | RegulatoryAssets | Regulatory Assets | USD | 2.00M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | RelatedPartiesAmountInCostOfSales | Related Parties Amount in Cost of Sales | USD | 13.15M | 2022-08-01 | 2022-08-08 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071154 |
| us-gaap | RepaymentsOfLongTermDebt | Repayments of Long-term Debt | USD | 39,990 | 2004-05-25 | 2014-03-31 | 2014 | Q3 | 8-K | 2014-05-27 | 0001213900-14-003773 |
| us-gaap | RepaymentsOfNotesPayable | Repayments of Notes Payable | USD | 50,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0001213900-23-022463 |
| us-gaap | ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount | Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount | pure | 0.01 | 2022-08-16 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071154 | |
| us-gaap | ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross | Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross | USD | 3.98M | 2014-07-01 | 2015-06-30 | 2015 | FY | 10-K | 2015-09-11 | 0001213900-15-006928 |
| us-gaap | ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationFairValueAcquired | Research and Development Asset Acquired Other than Through Business Combination, Fair Value Acquired | USD | 3.75M | 2013-07-01 | 2014-03-31 | 2015 | Q3 | 10-Q | 2015-05-15 | 0001213900-15-003882 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 25.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | ResearchAndDevelopmentInProcess | Research and Development in Process | USD | 2,800 | 2014-07-01 | 2014-09-30 | 2015 | Q1 | 10-Q | 2014-11-07 | 0001213900-14-007845 |
| us-gaap | RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings | Restricted Stock, Shares Issued Net of Shares for Tax Withholdings | shares | 1.93M | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-11 | 0001213900-23-038533 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -744.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | RetainedEarningsAppropriated | Retained Earnings, Appropriated | USD | 560.90M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 | |
| us-gaap | Revenues | Revenues | USD | 15,602 | 2011-05-23 | 2014-02-28 | 2014 | Q2 | 10-Q | 2014-04-15 | 0001255294-14-000328 |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 17 | 2021-12-08 | 2022 | FY | 10-K | 2023-03-23 | 0001213900-23-022463 | |
| us-gaap | SalesAndExciseTaxPayableCurrent | Sales and Excise Tax Payable, Current | USD | 275 | 2013-05-31 | 2013 | Q3 | 10-Q | 2013-07-12 | 0001255294-13-000523 | |
| us-gaap | SalesTypeLeaseInitialDirectCostExpenseCommencement | Sales-type Lease, Initial Direct Cost Expense, Commencement | USD | 213,500 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0001213900-23-084737 |
| us-gaap | SalesTypeLeaseSellingProfitLoss | Sales-type Lease, Selling Profit (Loss) | USD | 96,403 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0001213900-23-064519 |
| us-gaap | SecuritiesPurchasedUnderAgreementsToResellIncrease | Securities Purchased under Agreements to Resell, Increase | USD | 496,914 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 |
| us-gaap | SettlementLiabilitiesCurrent | Settlement Liabilities, Current | USD | 250,000 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-24 | 0001213900-21-017556 | |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 2.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 | Share-based Payment Arrangement, Expensed and Capitalized, Amount | USD | 62.39M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding | USD | 3 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001213900-24-095398 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested | USD | 0 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-13 | 0001213900-25-109983 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares | 157,811 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0001213900-23-064519 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 4.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Intrinsic Value, Amount Per Share | USD/shares | 1.83 | 2014-07-01 | 2015-03-31 | 2015 | Q3 | 10-Q | 2015-05-15 | 0001213900-15-003882 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 0.001 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 6.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | USD/shares | 2.66 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions | pure | 0.039 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001213900-26-055059 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 1.29 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 1.141 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001213900-24-095398 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 1.135 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001213900-24-095398 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.042 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.045 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001213900-24-095398 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.041 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001213900-24-095398 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised | shares | 74,999 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001213900-24-095398 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures | shares | 567,911 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-07 | 0001213900-24-066111 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations | shares | 15,040 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-25 | 0001213900-22-015012 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted | shares | 930,000 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0001213900-21-058454 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Other | shares | 1.02M | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-12 | 0001213900-20-021649 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | shares | 110,000 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001213900-24-095398 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares | 2.41M | 2013-12-31 | 2014 | FY | 10-KT | 2014-09-09 | 0001213900-14-006474 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares | 2.50M | 2023-05-31 | 2024 | Q1 | 10-Q | 2024-05-08 | 0001213900-24-040856 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 16.20M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001213900-26-055059 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 10.80M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001213900-26-055059 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 16.69 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001213900-26-055059 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 4.76M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001213900-24-095398 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 165,939 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0001213900-23-084737 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 19.16 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0001213900-23-064519 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 125 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001213900-26-055059 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | shares | 13.05M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 487,434 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001213900-24-095398 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 1.38 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | shares | 74,999 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares | shares | 15,000 | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-11 | 0001213900-23-038533 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 37.92M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001213900-26-055059 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 15.02M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001213900-26-055059 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 12.51 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001213900-26-055059 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | shares | 2.83M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0001213900-23-064519 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price | USD/shares | 20.36 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0001213900-23-084737 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 11.18M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 17.42M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 12.99 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 915,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | shares | 135,400 | 2014-07-01 | 2015-06-30 | 2015 | FY | 10-K | 2015-09-11 | 0001213900-15-006928 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period | shares | 487,434 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0001013762-25-003426 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward | Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award | shares | 61,484 | 2019-07-01 | 2019-12-31 | 2019 | FY | 10-KT | 2020-03-26 | 0001213900-20-007501 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 32.11 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0001213900-23-064519 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 3.1 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001213900-24-095398 |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit | USD/shares | 2.48 | 2023-11-13 | 2023-12-15 | 2024 | FY | 10-K | 2025-03-27 | 0001013762-25-003426 |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding | shares | 50,000 | 2023-03-31 | 2024 | Q1 | 10-Q | 2024-05-08 | 0001213900-24-040856 | |
| us-gaap | SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 | Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price | USD/shares | 10 | 2023-03-31 | 2024 | Q1 | 10-Q | 2024-05-08 | 0001213900-24-040856 | |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit | Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit | USD/shares | 2.82 | 2023-11-13 | 2023-12-15 | 2024 | FY | 10-K | 2025-03-27 | 0001013762-25-003426 |
| us-gaap | ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate | pure | 0.98 | 2021-12-27 | 2022-01-02 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001213900-22-024229 |
| us-gaap | SharePrice | Share Price | USD/shares | 2.2 | 2025-11-05 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001213900-26-055059 | |
| us-gaap | SharesIssued | Shares, Issued | shares | 2.80M | 2022-12-21 | 2022 | FY | 10-K | 2023-03-23 | 0001213900-23-022463 | |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 7 | 2018-09-30 | 2020 | Q1 | 10-Q | 2019-11-13 | 0001213900-19-023219 | |
| us-gaap | ShorttermDebtFairValue | Short-term Debt, Fair Value | USD | 104.06M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0001213900-23-064519 | |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 196.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | ShortTermLeasePayments | Short-term Lease Payments | USD | 160.00M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0001213900-23-064519 |
| us-gaap | StateAndLocalIncomeTaxExpenseBenefitContinuingOperations | State and Local Income Tax Expense (Benefit), Continuing Operations | USD | 4,425 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 |
| us-gaap | StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants | USD | 19,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 193.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 | |
| us-gaap | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | USD | 166.34M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071154 | |
| us-gaap | StockholdersEquityOtherShares | Stockholders' Equity, Other Shares | shares | 166,482 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071154 |
| us-gaap | StockIssued1 | Stock Issued | USD | 4.50M | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-08 | 0001213900-24-040856 |
| us-gaap | StockIssuedDuringPeriodSharesAcquisitions | Stock Issued During Period, Shares, Acquisitions | shares | 427,700 | 2020-01-01 | 2020-06-30 | 2021 | Q2 | 10-Q | 2021-08-10 | 0001213900-21-041369 |
| us-gaap | StockIssuedDuringPeriodSharesIssuedForServices | Stock Issued During Period, Shares, Issued for Services | shares | 3.90M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-25 | 0001213900-22-015012 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 29.47M | 2026-03-09 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001213900-26-086151 | |
| us-gaap | StockIssuedDuringPeriodSharesOther | Stock Issued During Period, Shares, Other | shares | 19.79M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-24 | 0001213900-21-017556 |
| us-gaap | StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited | Stock Issued During Period, Shares, Restricted Stock Award, Forfeited | shares | 10,000 | 2014-07-01 | 2015-06-30 | 2015 | FY | 10-K | 2015-09-11 | 0001213900-15-006928 |
| us-gaap | StockIssuedDuringPeriodSharesRestrictedStockAwardGross | Stock Issued During Period, Shares, Restricted Stock Award, Gross | shares | 104,000 | 2014-07-01 | 2015-06-30 | 2015 | FY | 10-K | 2015-09-11 | 0001213900-15-006928 |
| us-gaap | StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures | Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures | shares | 94,000 | 2014-07-01 | 2015-06-30 | 2015 | FY | 10-K | 2015-09-11 | 0001213900-15-006928 |
| us-gaap | StockIssuedDuringPeriodSharesShareBasedCompensationGross | Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture | shares | 1.61M | 2014-12-01 | 2014-12-31 | 2016 | Q2 | 10-Q | 2016-02-05 | 0001213900-16-010641 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 3.02M | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-12 | 0001213900-25-042025 |
| us-gaap | StockIssuedDuringPeriodValueAcquisitions | Stock Issued During Period, Value, Acquisitions | USD | 75.00M | 2020-05-01 | 2020-05-15 | 2021 | Q2 | 10-Q | 2021-08-10 | 0001213900-21-041369 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfUnits | Stock Issued During Period, Value, Conversion of Units | USD | 11.80M | 2018-07-01 | 2019-06-30 | 2020 | FY | 10-K | 2021-03-24 | 0001213900-21-017556 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForCash | Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) | USD | 1.50M | 2007-01-01 | 2007-12-31 | 2014 | Q3 | 8-K | 2014-05-27 | 0001213900-14-003773 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForServices | Stock Issued During Period, Value, Issued for Services | USD | 204,534 | 2015-07-01 | 2016-06-30 | 2017 | FY | 10-K | 2017-09-28 | 0001213900-17-010097 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 150.38M | 2026-01-01 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | StockIssuedDuringPeriodValueOther | Stock Issued During Period, Value, Other | USD | -65,651 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001213900-26-055059 |
| us-gaap | StockIssuedDuringPeriodValuePurchaseOfAssets | Stock Issued During Period, Value, Purchase of Assets | USD | 5,127 | 2012-01-01 | 2012-12-31 | 2014 | FY | 10-KT | 2014-09-09 | 0001213900-14-006474 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardGross | Stock Issued During Period, Value, Restricted Stock Award, Gross | USD | 905,226 | 2025-01-01 | 2025-03-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 1.20M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 246,747 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 |
| us-gaap | StockOptionExercisePriceIncrease | Stock Option, Exercise Price, Increase | USD/shares | 0.65 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-13 | 0001213900-25-109983 |
| us-gaap | StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased | Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased | shares | 4.00M | 2014-03-10 | 2014 | FY | 10-KT | 2014-09-09 | 0001213900-14-006474 | |
| us-gaap | SubleaseIncome | Sublease Income | USD | 2,350 | 2017-07-01 | 2018-06-30 | 2018 | FY | 10-K | 2018-09-28 | 0001213900-18-013238 |
| us-gaap | TaxCreditCarryforwardAmount | Tax Credit Carryforward, Amount | USD | 740,000 | 2022-10-13 | 2024 | FY | 10-K | 2025-03-27 | 0001013762-25-003426 | |
| us-gaap | TaxesAndLicenses | Taxes and Licenses | USD | 45,000 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-12 | 0001213900-25-042025 |
| us-gaap | TreasuryStockCommonShares | Treasury Stock, Common, Shares | shares | 1.45M | 2022-09-20 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071154 | |
| us-gaap | TreasuryStockCommonValue | Treasury Stock, Common, Value | USD | 1.45M | 2022-09-20 | 2023 | FY | 10-K | 2024-03-19 | 0001213900-24-024013 | |
| us-gaap | UnearnedPremiums | Unearned Premiums | USD | 2,300 | 2022-03-31 | 2023 | Q1 | 10-Q | 2023-05-11 | 0001213900-23-038533 | |
| us-gaap | UnrealizedGainLossOnDerivatives | Unrealized Gain (Loss) on Derivatives | USD | 290,973 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001213900-20-036542 |
| us-gaap | UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments | USD | -3.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | UnrealizedLossOnSecurities | Unrealized Loss on Securities | USD | 290,973 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001213900-20-036542 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense | Unrecognized Tax Benefits, Income Tax Penalties Expense | USD | 300,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001213900-24-095398 |
| us-gaap | UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense | Unrecognized Tax Benefits, Interest on Income Taxes Expense | USD | 6.20M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0001213900-23-022463 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 122.50M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001213900-26-031862 |
| us-gaap | WarrantExercisePriceDecrease | Warrant, Exercise Price, Decrease | USD/shares | 0.1 | 2021-01-01 | 2021-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071154 |
| us-gaap | WarrantExercisePriceIncrease | Warrant, Exercise Price, Increase | USD/shares | 0.001 | 2022-09-01 | 2022-09-20 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071154 |
| us-gaap | WarrantsAndRightsOutstanding | Warrants and Rights Outstanding | USD | 437,100 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001213900-20-036542 | |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 103.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 17.55M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-25 | 0001213900-22-015012 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 103.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118916 |